TW200533566A - Method of transporting medicaments - Google Patents

Method of transporting medicaments Download PDF

Info

Publication number
TW200533566A
TW200533566A TW094107674A TW94107674A TW200533566A TW 200533566 A TW200533566 A TW 200533566A TW 094107674 A TW094107674 A TW 094107674A TW 94107674 A TW94107674 A TW 94107674A TW 200533566 A TW200533566 A TW 200533566A
Authority
TW
Taiwan
Prior art keywords
medicine
tank
mentioned
user
tank container
Prior art date
Application number
TW094107674A
Other languages
Chinese (zh)
Inventor
Shigefumi Morohoshi
Original Assignee
Morohoshi Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2004090182A external-priority patent/JP3922377B2/en
Priority claimed from JP2004221750A external-priority patent/JP3806722B2/en
Application filed by Morohoshi Inc filed Critical Morohoshi Inc
Publication of TW200533566A publication Critical patent/TW200533566A/en

Links

Classifications

    • HELECTRICITY
    • H02GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02GINSTALLATION OF ELECTRIC CABLES OR LINES, OR OF COMBINED OPTICAL AND ELECTRIC CABLES OR LINES
    • H02G15/00Cable fittings
    • H02G15/08Cable junctions
    • H02G15/18Cable junctions protected by sleeves, e.g. for communication cable
    • H02G15/184Cable junctions protected by sleeves, e.g. for communication cable with devices for relieving electrical stress
    • HELECTRICITY
    • H02GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02BBOARDS, SUBSTATIONS OR SWITCHING ARRANGEMENTS FOR THE SUPPLY OR DISTRIBUTION OF ELECTRIC POWER
    • H02B1/00Frameworks, boards, panels, desks, casings; Details of substations or switching arrangements
    • H02B1/26Casings; Parts thereof or accessories therefor
    • H02B1/28Casings; Parts thereof or accessories therefor dustproof, splashproof, drip-proof, waterproof or flameproof
    • HELECTRICITY
    • H02GENERATION; CONVERSION OR DISTRIBUTION OF ELECTRIC POWER
    • H02GINSTALLATION OF ELECTRIC CABLES OR LINES, OR OF COMBINED OPTICAL AND ELECTRIC CABLES OR LINES
    • H02G15/00Cable fittings
    • H02G15/007Devices for relieving mechanical stress

Landscapes

  • Engineering & Computer Science (AREA)
  • Power Engineering (AREA)
  • Catching Or Destruction (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

To provide a method of transporting medicaments for transporting powder-state medicaments which is dissolved in solvent for use safely and further efficiently from a storage warehouse of a supplier to a receiving place of an user, dissolving quickly into solution of a predetermined concentration, and delivering the same. A method of transporting medicaments in which powder-state medicaments which is dissolved in solvent for use is transported and delivered to an user includes Step S1 of storing a bag containing the medicament by a predetermined weight in a storage warehouse, Step S2 of opening the bag containing the medicament, and feeding the medicament into a tank container and retaining the same in the powder state therein for delivering the same to the user, Step S3 of transporting the medicament retained in the tank container to a medicament receiving place of the user by a trailer, Step S4 of supplying solvent and vapor to the tank container at the medicament receiving place, and mixing and dissolving the medicament to obtain solution of a predetermined concentration, or Step S4A of supplying solvent from a solvent retaining and dissolving tank disposed at the medicament receiving place to the interior of the tank container, mixing and circulation to dissolve the medicament to obtain solution of a predetermined concentration, and Step S5 of supplying the medicament solution dissolved in Step S4 or in Step S4A to a storage tank of the user.

Description

200533566 '九、發明說明: 【發明所屬之技術領域】 本發明主要是關於藥品輸送的方法,以及 於溶劑的粉狀藥品,以安全有效的自供 ^疋關於傳送溶 =接收處’快速溶解成既定相同的遭度來供應,二用戶 洛液給用戶。 /、應相同的藥品 【先前技術】 >挪白:=所述’溶於溶劑中的粉狀藥物的例子,用於造紙工廠來 你白紙漿的氧化漂白劑之氯酸鈉。 、·氏工廠末 在習知技述中,傳送氯酸鈉(此後 =為用戶)的方法般包括以下步驟,在售方(此)二= 如==司的危險物品儲存倉庫2中館存含有一二 一谷^如一袋子中,將上述容㈣载到運送卡車3上運:V身 口口 要求至上述用戶的藥品運 /述樂 之範例。 弟所不之工作程序(流程) 直到:=時:戶收 (cHSS〇luti〇n-specifi ) U時,百先由特定釋放 述容器!,接著將先,以丄、自上述危險物品儲存倉庫钟取出上 、則粕狀儲存的上述藥品Μ放入由溫水供 供應溫水的溶解槽5中,再由混合抑合溶解,再m應裝置—6 浪度^容液由液體輸入幫浦8傳送到儲存槽8直到漂白。-既疋 高二寻已不:上定常強的氧化材咖 有害材料,因此,當上述荜=材料接觸時容易被點燃,爆炸或產生 上述用戶必須得到關;上述習知之藥品傳送方法運送時, 儲存處理上述藥品Μ的既定許可,故有一關於 2049-6929-PF;Ahddub 6 200533566 ,設備安裝的結構或地點之特定規範標準來儲存或溶解等相, 更進-步,上述用戶不願施行如溶解等工作,因為至少 定的員工來施行上述溶解工作。 而 名特 因此’在習知技術中,如第22圖所示般傳送藥 上述供應端具㈣品溶解裝置,如上述溶解槽5,上述 穿置 6’上述混合器7’上述液體輸入幫浦8等,當傳送藥品m至用置 供“自危險物品儲存倉庫2中取出含有藥品_ : i,並在藥品溶解設施中準備一既定濃度的藥品 減至料_槽容器13 ,上述拖車1〇包括牵引機u,起落 上述槽谷益13,並利用上述拖車將上述藥品容液運送 然而,上述傳送藥品的方法,就上述供應端 ,=二 藥品溶液溶解在溫水中,由容量和重量有限的槽容器 ^僅運n的例子巾,可能降低單㈣品 險’而當運送的過財溫度降低(如降到⑽)…=羊的危 到過飽合的狀態,因此可能分出蛀日 〜合液可迠破帶 是當運送上述藥品Μ到寒冷地區時, L個問通,就 制了運送範圍。 運騎間不此太長,因此限 相反的,在上述用戶接受端的立場,雖然 藥品Μ的的設施以及特殊操件 工; 子溶解上述 結省成本,但是產生了在運η” ^貝不疋必須的’而能有所 生了在運廷上述樂品M的價格增加的問題。 【發明内容】 辦加上述?1:了 ,Γ於拖車的道路交通法律的規範寬鬆,而因此 :加上边取大重1到35到4㈣,本發明的目標在轉供—筚品傳、英 二方法、:傳达溶於溶劑的粉狀藥品,以安全有效的自供應二 倉庫傳送到用戶的接收處,快速 /、Μ 、:子 解成既疋相同的濃度來供應,以 2049-6929-PF;Ahddub 7 200533566 - 供應相同的藥品給用戶。 本發明的上述目標在於藉荖薤0 的粉狀藥品,以供應上述藥方:’達到傳送溶於溶劑 有一既定重量的藥品於袋子中麵;;=丄包括:步驟S1 ’儲存含 述藥品的袋子,放人上述筚=存^房#;步驟S2,打開含有上 中,力卜、十、播々抑 ’、至槽谷器並在運送到用戶的過程 車運送含有中保持上述在藥品的粉末狀態;步驟s3,利用拖 的槽容器到上述用戶的藥品接收處;步⑽, 藥品蒸氣至上述槽容器, 解的藥品溶液到上述用戶的及步驟S5,供應在上述步驟S4溶 本發明的上述目標在於藉著 溶劑的粉狀藥品,以供應相同==法效達到傳送溶於 含右一叫―壬θ 耵杀0口給用戶,包括··步驟S1,儲在 有上述str品於—袋子中在儲存庫房中,·步㈣’打開含 有上这L的袋子,放入上述藥品至 程中,在上述槽容器中保持 《谷並在運达到用戶的過 拖車運送含有上述藥品的槽容述=品的粉末狀二態;步驟S3,利用 S4A,在上述藥。接收卢曰谷态|上述用戶的藥品接受處;步驟 溶液;以及步驟S5,供岸在衣:解上迷樂品而得到一既定濃度的 的儲存槽。 應在上迷步驟8録解的藥品溶液到上述用戶 溫水。 _ '上述粉狀藥品為氯酸鈉,而溶劑為 藉著提供-藥品輸送方 上述藥品輸送方法 有政違到本發明先别提到的目的, 藉著提… 於’上述溶劑由用戶提供。 I樂品輸送方法來有效達到本發明先前提到的目的, 2049-6929-PP/Ahddub 8 200533566 ,上述藥品輪送方法之 =度方向位置排出而料在持溶解槽的 在上述槽容器内部混合,自上述槽 :的底4而注入内部, 述溶劑保持溶解槽的底 曰^〜方向位置排出,而自上 藉箸提供-藥品輸溶解槽内部。 上述藥品輸送方法之特徵在於,當上綱二:二提到的目的, 的底部回到上述溶劑保持溶解槽内部時,上述、容·持溶解槽 到的目的,上述藥品輸送方法法來有效達到本發明先前提 由清洗水清洗上_器表t = /品在步職中注入後, 溶液時重覆利用上述清洗水。*解上相品至-既定濃度的 [優點:! 如以上所述’本發明為一種輸口 品被保存在上述槽容器中,由供應顧狀=的方法,上述粉狀藥 藉著在供應側的槽容器内混合循環,或:藉著的接:處, ,供應側的槽容器和用戶側的溶劑保存溶解槽之,:以::::筚 品,而準備供虞戶斤裳、、_降&越σ、— 解上述梁 根據本發明,二用^不需使用端的儲存槽’因此, 七么 要昶狀樂品的儲存控(故不需要且右Μ 二本亦™殊的I作者來執行儲存溶解,使 相反地,上述藥品以粉狀被運輸,比較以液態運 用戶端的成本減少),顯著的增加每單位的藥品運送效率(㈣= 術多兩倍而且’因為少數的員工可以執行輪送到溶解的一 工作’可觀的減少輸送費用並可達到運輪空間的放大和改善輸送效 率〇 、 特別是’如以上所述,在最近拖車重量自35嘴到Μ嘲重的放寬, 2049-6929-PF;Ahddub 9 200533566 •較習知技術的運送效率可以改善有87%之多。 根據本發明,在供應侧的槽容和用p 間,執行上述粉狀筚品的混人㈣和用戶側的㈣保存溶解槽之 果口口的此口循J展,可在短時間 因此可大量的節省成本。 Μ旱備大里的溶劑, 更進步,根據本發明,上述槽容器的藥品注 粉塵散出的功能和吸粉功能’而附著和殘留在上述槽^表、、 ^上述“,皆被清洗後回收再使用,可以避免上述藥=面内放^ 因此,達到南安令辦進买料 0釋 门女王私準和對裱境友善的藥品輸送方法。 【實施方式】 的詳=!將=_鋼(此後稱為藥品心的例子做最佳實施例 藝者,在不脫離本發明之精神和範圍内,當可作更動相頁技 第】圖所示為根據本發明之第i實施例(此後稱為第輸送 納溶方:程序示意圖’為-流程圖顯示粉㈣ ==:1Γ 液並以根據上述相關習知技術輸送藥品的 方法錯存之步驟,在第一藥品輸送方法的敛述中 #關習知技術的藥品輸送方 =述之相 仟具有一樣的參考標號。 使^方法為一輸送藥品的方法,其中包含可混合溶解 使私狀樂4讀可溶解上述粉狀藥品的溶财,以得到— 法=容液接著由拖車lG°傳送運送到使用端:上又 子步驟1s’裝載一既定重量的藥品μ至一袋 柔軟容哭可彎曲並具有一強度(所謂國際標準中所定義的 的袋子;;,, 儲存倉庫2中,步驟2S,打開含有上述藥品Μ : J入上逑樂品胁槽容器130中’並在運送到用戶的過程 ”寺上述樂品Μ為粉末狀態,步驟3S,以拖車⑽運送含有上述藥 2049-6929-PF;Ahddub 10 200533566 -品Μ的槽容器130至上述用戶的藥品接收處180,步驟4S,在上述用戶 藥品接收處注入由客戶提供的溫水和蒸汽到上述槽容器13〇中,混合 洛解上述藥品Μ成一既定濃度的溶液,以及步驟5S,將步驟4S中溶解 所得的藥品溶液注入上述用戶的儲存槽9中。 上述拖車100包括牽引機110,起落架120,以及槽容器130如第2 圖中的側視概略圖所示。 上述槽容器130為一為ISO標準的BV合格產品,由約六公尺長, 直徑2. 4公尺,重約4噸的圓筒環狀壁131所形成,如第3(〇圖的側視 纠面圖,第3(B)圖的平面圖和由第3(A)圖X-X線所得之剖面側視第 3(C)圖所示,且包括兩個注入口 i32(上述入口 IK具有一保護蓋 132C,故可開關),以在上述槽容器13〇上側將上述藥注入上述槽 各态130内部,混合裝置133以混合被注入的上述藥品μ,導管固定口 134以固定排出導管13如,以及超音波液位偵測器139,因為道路交 通法的管制,上述拖車100裝載上述槽容器13〇的最高高度為3.8公尺 之狀態,上述混合器133被存放在上述槽容器130中直到上述藥品μ 被輸送到上述用戶的接收處18〇如之後所述。 兩個分開的循環管以水平方向分別位於上述環狀壁131的上側 修和下側,上述循環管135的側壁具有複數喷嘴135η,以一規則間斷注 入溫水或蒸氣,而上述藥品Μ也由溫水或水蒸汽溶解如之後所述,上 述裱狀壁131的較下端處具有排出口 137以移除殘餘的溶液。 如第4圖的立體圖所示,用來收集清洗水的集水溝槽13化位於上 述環狀壁131外表面側面以便於環繞在環狀壁13ι,而收集溝槽13扑 連接上述集水溝槽136a,如之後所述,以水清洗上述槽容器13〇如箭 頭γι所示,上述清洗用過的清洗水流過上述集水溝槽136a,i36b排 出到污水管如箭頭Y2所示。 上述排出導管134d透過灰塵收集瀘器134f連接到外部排出風箱 2049-6929-PF;Ahddub 11 200533566 ‘故注入上述藥品财至槽容器130時所產生的粉塵由外部容器所 集’外部谷器未示於圖上,遠接卜〔於鹿&巷 ™ α上運接上述私塵收集濾器134f的上述排 出導官134d和上述外部排出風箱腿事先位於上述拖車上, =排出風If 134b連接到-獨立的電源供應器(詩風箱馬達和内建 ttf卜置之電源供應器),示未於圖上,固定在上述拖車⑽的起落 ^ m制立的電源供應n驅動上料料出風箱134b, 上述设備亦可由用戶提供。 的槽斤述’上述第一藥品輸送方法中的槽容器130和一般所知 5,不同在於混合和溶解上述藥品Μ的裝置,避免上述藥 。口 Μ四散各處的裝置,以及收集清洗水的裝置。 ’、 接著’保存在上述槽容器130中的上述藥品Μ的程序設計如以上 =二上述拖車100輸送上述藥品_上述用戶藥品接收處⑽,準 ,『樂品Μ的最佳濃度之溶液,以及注人上述溶液至上述用戶 存槽二’上述方法將在以下各步驟中,連同所需之設備作詳細敘述。 ^驟1S中’被樂品製造商輸送到上述供應端的上述藥品存 u供應端的危險材料儲存倉庫2中,上述藥品通常以…镇 位填充於上述袋子1Ft,而且以-既定安全控制標準保存。 130中士’在ί述袋子1F中的上述藥品輸送到上述槽容器 材料儲/ΛΓ 沿著白線將上述拖車100倒車進入上述危險 上述絮1=㈣輸室中、然後以—車輛停止11停在—既定位置, 逃駕驶讀具有處理危險材料和藥品的資格,在上述傳輸室中, ==中附著在上述槽容議表面的灰塵,粉末或污泥都會如 nfj ’而上述使㈣的清洗水、㈣上耗水構槽咖和 136b排到上述污水管為一預備程序。 外邦=’在々上述排出管U4d接到上述導管固定口 134後,啟動上述 d iSU目134b’而上述槽容器13Q的内部被帶至負壓力的狀態, 2049-6929-PF;Ahddub 12 200533566 v因此,上述藥品散地經由上述注入口 132反向流入注入,因此避 免排出外面,同時,空氣控制的上述藥品放在上述槽容器13〇中由上 述私塵濾裔13 4 f過濾,因此僅排出乾淨的空氣。 再來,打開位於上述兩個注入口 132上以便開關的保護蓋i32c, 而上述藥品Μ分別經過由起吊裝置16〇打開的上述注入口 132注入。200533566 'IX. Description of the invention: [Technical field to which the invention belongs] The present invention is mainly related to the method of drug delivery, and powdered drugs in solvents, to provide safe and efficient self-supply To supply the same damage, two users Luoye to the user. / 、 Should be the same drug [Prior art] > Norway white: = The example of the powdered drug dissolved in the solvent, used in the paper factory to oxidize the bleach of white pulp, sodium chlorate. At the end of the factory, in the conventional technical description, the method of delivering sodium chlorate (hereafter = for the user) generally includes the following steps, which are stored in the seller's (here) two = such as == company's dangerous goods storage warehouse 2 in the library Contains one, two, one grains ^ As a bag, the above contents are carried on the delivery truck 3: V is an example of a medicine delivery / shule that requires the mouth to the user. The working procedure (flow) that my brother does not know Until: = Hour: Household income (cHSS〇luti〇n-specifi) U, the container will be released by the specific one! Then, the medicine M stored in the form of a meal is put into a dissolution tank 5 supplied with warm water from warm water, and then dissolved by mixing and suppression, and then m Responder—6 The liquidity is transferred from the liquid input pump 8 to the storage tank 8 until bleached. -Neither high school nor high school: the oxidized materials that are always strong, harmful materials, so when the above materials are easily ignited when in contact with the material, the explosion or the above-mentioned users must be closed; when the conventional drug delivery methods are transported, stored The given permission to deal with the above-mentioned drug M, so there is a specific normative standard for 2049-6929-PF; Ahddub 6 200533566, the structure or location of the equipment installation to store or dissolve the phases, etc. Further, the above-mentioned users are unwilling to implement such as dissolution Wait for the job, because at least a predetermined number of employees will perform the above dissolution work. Mingte therefore 'in the conventional technology, as shown in Figure 22, the above-mentioned supply side is equipped with a counterfeit dissolving device, such as the dissolving tank 5, said penetrating 6', said mixer 7 ', and said liquid input pump. 8 and so on, when the drug m is transported to the facility for use, "the drug containing _: i is taken from the dangerous goods storage warehouse 2 and a predetermined concentration of the drug is reduced to the material tank in the drug dissolving facility. It includes a tractor u, which lifts and lowers the above-mentioned trough valley 13 and uses the trailer to transport the medicine-containing liquid. However, the method for transferring medicines, as far as the supply side, is that the two medicine solutions are dissolved in warm water. The trough container ^ only transports the example towel of n, which may reduce the single product quality risk, and when the temperature of the richness of the shipment is reduced (such as to ⑽) ... = the sheep is in a state of oversaturation, so it may be separated into the next day ~ The rupture zone of the fluid is when the medicine M is transported to a cold area, L interrogates, and the transportation range is established. The transportation room is not too long, so the limit is the opposite. At the above-mentioned user's standpoint, although the medicine Facilities of Μ And special work operation member; dissolving the child node cost-saving, but is generated in the transport η "^ Cloth shell must not 'be able to be born in price ting operation of the above-described music article M increases. [Summary of the Invention] To add the above? 1: Yes, the road traffic laws of the trailer are loosely regulated, and therefore: plus the side of the heavy weight of 1 to 35 to 4㈣, the goal of the present invention is to transfer-筚 品 传, 英 二Method: convey the powdered medicine dissolved in the solvent, and transfer it to the user's receiving place from the second warehouse of supply safely and efficiently, and quickly /, M, and: will be decomposed to the same concentration to supply, 2049-6929- PF; Ahddub 7 200533566-Supply the same medicines to users. The above-mentioned object of the present invention is to supply the above prescription by means of a powdered medicine of 荖 薤 0: 'to achieve the delivery of a medicine of a predetermined weight dissolved in a solvent to the inside of the bag; = 丄 includes: step S1' storing a bag containing the medicine Put the above 打开 = 存 ^ 房 #; Step S2, open the powder containing the upper, middle, lower, upper, lower, and lower sides, go to the trough device and transport the powder to the user to keep the powder in the medicine in the process. State; step s3, using the dragged tank container to the above-mentioned user's medicine receiving place; step ⑽, the drug vapor to the above tank container, the decomposed drug solution to the above-mentioned user and step S5, supplying the above-mentioned step S4 dissolving the present invention The goal is to supply powdered medicines with the same solvent to supply the same == method to achieve dissolution. Dissolve the mouth containing the right one-壬 θ to kill 0 mouths to the user, including · Step S1, stored in the above-mentioned str product in the bag. In the storage warehouse, ···· 打开 Open the bag containing the above L, put the medicines into the process, keep the "valley and the tank containing the medicines in the trough container" = Product Last binary form; step S3, the use S4A, in the above-described drugs. Receiving Lu Yuegu State | The medicine accepting place of the above user; step solution; and step S5, the shore supply: dissolve the fun products and obtain a storage tank of a predetermined concentration. The drug solution recorded in step 8 should be added to the above user warm water. _ 'The above powdered medicine is sodium chlorate, and the solvent is provided by-the drug delivery side. The above drug delivery method is contrary to the purpose of the present invention, and by mentioning ... The above-mentioned solvent is provided by the user. I The music product conveying method is effective to achieve the aforementioned purpose of the present invention, 2049-6929-PP / Ahddub 8 200533566. The above-mentioned medicine rotation method is discharged at the position of the degree direction, and the materials are mixed in the tank container holding the dissolution tank. The solvent is injected into the interior from the bottom 4 of the above tank, and the solvent is discharged from the bottom of the dissolution tank in the direction of ^ ~, and the medicine is supplied from the top to the inside of the dissolution tank. The above-mentioned drug delivery method is characterized in that when the bottom mentioned in the second and the second mentioned above returns to the inside of the solvent holding dissolution tank, the above purpose of holding and holding the dissolution tank is effectively achieved by the above-mentioned drug delivery method. According to the present invention, the upper surface of the device is cleaned by the washing water t = / injected in the step, the solution is repeatedly used when the solution is used. * Solve the photo quality to the given concentration [Pros :! As described above, the present invention is a method in which an infusion product is stored in the above-mentioned tank container, and the supply of the powder medicine is circulated by mixing in the tank container on the supply side, or: : Where, the tanks on the supply side and the solvent storage tanks on the user's side dissolve the tanks with ::::: forged products, and prepare them for use by Yu Hu Jin Sang, _ 降 & 越 σ, — Invented, two uses ^ do not need to use the storage tank 'Therefore, Qime has to control the storage of the music product (so it is not necessary and right) the two authors to perform storage dissolution, so that on the contrary, the above medicine Being transported in powder form reduces the cost compared to transporting the client in liquid state, significantly increasing the efficiency of drug delivery per unit (㈣ = twice as much surgery and 'because a small number of employees can perform a job of dissolving in rotation') considerable Reduce the transportation cost and can enlarge the shipping space and improve the transportation efficiency. Especially, as mentioned above, the recent trailer weight has been relaxed from 35 nozzles to M, 2049-6929-PF; Ahddub 9 200533566 Delivery efficiency of conventional technologies can be improved According to the present invention, in the tank capacity and the supply side of the supply side, the mixed product of the powdery product and the user-side product are used to store the fruit mouth of the dissolution tank. It can save a lot of cost in a short period of time. The solvent in the dry preparation is further improved. According to the present invention, the drug injection function and powder suction function of the above-mentioned tank container are adhered to and remain in the above-mentioned tank ^ Tables, and ^ "above are all recovered and reused after cleaning, which can avoid the above medicine = put in the face ^ Therefore, to achieve the Nan'an Order Office to buy the material and release the queen's private permission and friendly drug delivery method. 【 The details of the implementation] =! Will = _ steel (hereinafter referred to as the drug core example as the best embodiment of the artist, without departing from the spirit and scope of the present invention, when you can make changes to the page technology] It is a step according to the i-th embodiment of the present invention (hereinafter referred to as the first delivery solution: the program schematic diagram is shown as a flowchart showing the powder ㈣ ==: 1Γ liquid and the method of delivering drugs according to the above-mentioned related conventional technology , In the summary of the first drug delivery method # 关 习 知 技The drug delivery side = Said phase has the same reference numerals. Let ^ method be a method of drug delivery, which includes miscible properties that can be mixed and dissolved to dissolve the powdery drugs to obtain — method = The liquid container is then transported to the end of use by the trailer lG °: the first sub-step 1s' is loaded with a predetermined weight of medicine μ to a bag of soft, flexible, flexible and has a strength (the bag defined in the so-called international standards; ; ,, in the storage warehouse 2, step 2S, open the medicine containing the above-mentioned drug M: J into the Shangle music product flank tank 130 'and in the process of transporting it to the user "said music product M in a powder state, step 3S, to The trailer ⑽ transports the tank containing the above-mentioned medicine 2049-6929-PF; Ahddub 10 200533566-product M to the medicine receiving place 180 of the user, step 4S, injects warm water and steam provided by the customer to the medicine receiving place of the user to In the above-mentioned tank container 13, the above-mentioned medicine M is mixed into a solution of a predetermined concentration, and in step 5S, the medicine solution obtained by dissolving in step 4S is poured into the storage tank 9 of the user. The trailer 100 includes a tractor 110, a landing gear 120, and a tank container 130 as shown in a schematic side view in FIG. The above-mentioned tank container 130 is a BV-qualified product of the ISO standard, and is formed by a cylindrical annular wall 131 having a length of about six meters, a diameter of 2.4 meters, and a weight of about 4 tons, as shown in the side of FIG. 3 (〇 Viewing surface view, the plan view of FIG. 3 (B) and the cross-sectional side view taken from line XX of FIG. 3 (A) are shown in FIG. 3 (C), and include two injection ports i32 (the above-mentioned inlet IK has a The protective cover 132C can be opened and closed) to inject the above medicine into the above-mentioned tank state 130 on the upper side of the tank container 130, the mixing device 133 to mix the injected medicine μ, and the catheter fixing port 134 to fix the discharge catheter 13 such as As well as the ultrasonic liquid level detector 139, due to the regulations of the Road Traffic Act, the maximum height of the trailer 100 loaded with the tank container 130 is 3.8 meters, and the mixer 133 is stored in the tank container 130 until The medicine μ is delivered to the receiving place of the user 18 as described later. Two separate circulation tubes are horizontally located on the upper side and the lower side of the annular wall 131, and the side wall of the circulation pipe 135 has a plurality of nozzles. 135η, inject warm water or steam at regular intervals The medicine M is also dissolved by warm water or water vapor. As described later, the lower end of the mounting wall 131 has a discharge port 137 to remove the remaining solution. As shown in the perspective view of FIG. 4, it is used to collect and clean. The water collecting groove 13 is located on the outer surface side of the annular wall 131 so as to surround the annular wall 13m, and the collecting groove 13 is connected to the above-mentioned water collecting groove 136a. As described later, the groove is washed with water. As shown by the arrow γ in the container 13, the washing water used for the above-mentioned washing flows through the above-mentioned water collecting groove 136a, i36b and is discharged to a sewage pipe as shown by arrow Y2. The above-mentioned discharge duct 134d is connected to the external exhaust air through a dust collector 134f Box 2049-6929-PF; Ahddub 11 200533566 'Therefore, the dust generated when injecting the above medicine into the tank container 130 is collected by the external container' The external valley device is not shown in the figure, and it is remotely connected [at Lulu & Lane ™ The above-mentioned discharge guide 134d and the above-mentioned external exhaust bellows which are connected to the private dust collection filter 134f are located on the trailer in advance, = the exhaust air If 134b is connected to an independent power supply (the poetry bellows motor and the built-in ttf BU Zhi Power supply), not shown in the figure, fixed on the trailer ⑽ ^ m stand-alone power supply n drive the loading air outlet box 134b, the above equipment can also be provided by the user. A tank container 130 in a drug delivery method is different from the general known device 5, except that the device for mixing and dissolving the drug M described above avoids the drug. The device is scattered around the mouth M and the device for collecting washing water. The program design of the medicine M in the tank container 130 is as above = 2 The above-mentioned trailer 100 transports the medicine_the user's medicine receiving place above, “the optimal concentration of Lepin M solution, and inject the above solution to The above-mentioned user storage slot 2 'The above method will be described in detail in the following steps, together with the required equipment. ^ In step 1S, the medicine stored in the supply side at the supply side of the above-mentioned drug storage warehouse 2 transported by the music manufacturer to the above-mentioned supply side, the above-mentioned medicine is usually filled in the above-mentioned bag 1Ft in a ... position, and is stored under a predetermined safety control standard. 130 Sergeant 'The medicine in the bag 1F is transported to the tank container material storage / ΛΓ Along the white line, the trailer 100 is reversed into the above-mentioned danger 1 = ㈣ delivery room, and then-the vehicle stopped 11 parked at —Predetermined position, evasion driving has the qualification to handle dangerous materials and medicines. In the above transmission room, =, dust, powder or sludge attached to the surface of the above tank will be like nfj 'and the above-mentioned cleaning water will be used. It is a preparatory procedure to drain the water-consumption tank and 136b on the sewage pipe. Foreign State = 'After the above-mentioned discharge pipe U4d is connected to the above-mentioned duct fixing port 134, the above-mentioned d iSU head 134b is activated and the inside of the above-mentioned tank container 13Q is brought to a state of negative pressure, 2049-6929-PF; Ahddub 12 200533566 v Therefore, the above-mentioned medicine is scattered into the reverse injection through the above-mentioned injection port 132, so that it is prevented from being discharged outside. At the same time, the above-mentioned medicine controlled by air is placed in the above-mentioned tank container 13 and filtered by the above-mentioned private dust filter 13 4 f. Exhaust clean air. Then, the protective covers i32c located on the two injection ports 132 for opening and closing are opened, and the medicines M are injected through the injection ports 132 opened by the lifting device 160, respectively.

第5圖為藉著上述起吊裝置16〇將上述袋容器怀注入上述槽容器 130的注入口 132之平面圖,第6圖為上述第5圖狀態的侧視圖,上述 起吊裝置160包括起吊裝置162以沿著位於傳輸室屋頂的起吊軌道 \61上滑動,量測元件164透過電線163連接上述起吊裝置162,而接 著連接重里偵測自動搖動機構165和用來連接和分開上述袋子1F 的連接機構166,設定上述起吊裝置16〇以第5圖和第6圖的箭頭所示 方向移動。 在注入含有上述藥品Μ的袋容器ip之前,上述起吊裝置16〇以第5 圖中的箭頭(1)方向移動,而以漏斗形成的料斗167由上述起吊裝置 160控制,固定在上述兩個注入口 132的開口(第5圖中的位置&和位置 b),接著,上述起吊裝置160以箭頭(2),(24),(2一2),所示 方向移動,既定數量的上述袋子…一個個分別被夾起,並傳送到分 •別的料斗16 7位置(位置a和位置b ),在上述控制裝置的記憶體中編寫 儲存上述起吊裝置160自起始點到一自動停止位置(由分別的箭頭所 示之X-軸和y-軸方向)的距離,未示於圖中,因此,當上述施車ι〇〇 的停止位置有些偏差時,含有上述藥品M的上述袋子11?都會被精確的 傳送到上述注入口 132,因此,較沒有技術的工人可以實施上述藥品 注入工作,因而達到改善安全性和減少工時,當上述起吊裝置1 輸送上述袋子1F至上述料斗167的位置(位置a和位置…時,上述電線 163向下移動如第6圖的箭頭(3)所示,而上述袋容器1F進入上述料斗 167 ’然後,上述袋容器ip由稍後所述之切割刀片打開,上述藥品μ 2049~6929-PF/Ahddub 13 200533566 以粉末狀保存在上述槽容器13G中。 ,第7(A)圖和第7⑻圖所示為上述連接機構166的結構和運作方 式’上述連接機構166包括可以打開合起的嵌壁式聯接機構祕和位 於上述袋容H1F上端的突出連接機構祕,如第7(a)圖所示,上 電瘦163在上述嵌壁式連接機構166访開的狀態時,向下移動至上^ 突出連接機構166b的位置,而如第7(β)Β所示,上述钱壁式連接機 構166a在和上述突出連接機構166|3咬合時,合起並將上述袋子㈣FIG. 5 is a plan view of the injection port 132 for injecting the bag container into the tank container 130 through the lifting device 160, and FIG. 6 is a side view of the state in FIG. 5; the lifting device 160 includes a lifting device 162 to Sliding along the lifting track \ 61 on the roof of the transfer room, the measuring element 164 is connected to the above-mentioned lifting device 162 through a wire 163, and then connected to the automatic detection mechanism 165 and a connecting mechanism 166 for connecting and separating the above-mentioned bag 1F. , The above-mentioned lifting device 16 is set to move in the directions shown by the arrows in FIG. 5 and FIG. 6. Before the bag container ip containing the medicine M is injected, the lifting device 160 moves in the direction of arrow (1) in FIG. 5, and a hopper 167 formed by a funnel is controlled by the lifting device 160 and fixed to the two injections. The opening of the inlet 132 (position & and position b in FIG. 5). Then, the lifting device 160 moves in the directions shown by the arrows (2), (24), and (2-2), and a predetermined number of the above-mentioned bags … One by one is clamped and transferred to a separate hopper position 16 (position a and position b), and the storage device 160 is programmed to store the lifting device 160 from the starting point to an automatic stop position. The distances (X-axis and y-axis directions indicated by the respective arrows) are not shown in the figure. Therefore, when the stopping position of the truck 〇00 is slightly deviated, the bag 11 containing the medicine M described above 11 ? Will be accurately transferred to the above-mentioned injection port 132, so less skilled workers can perform the above-mentioned drug injection work, thereby improving safety and reducing man-hours, when the lifting device 1 transports the bag 1F to the hopper 16 Position 7 (position a and position ...), the electric wire 163 moves downward as shown by arrow (3) in FIG. 6, and the bag container 1F enters the hopper 167 '. Then, the bag container ip is described later The cutting blade was opened, and the above-mentioned medicine μ 2049 ~ 6929-PF / Ahddub 13 200533566 was stored in a powder state in the above-mentioned tank container 13G. Fig. 7 (A) and Fig. 7⑻ show the structure and operation of the above-mentioned connection mechanism 166 Method 'The above-mentioned connection mechanism 166 includes a recessed connection mechanism that can be opened and closed and a protruding connection mechanism that is located at the upper end of the bag volume H1F. As shown in FIG. 7 (a), the power thin 163 is installed in the recessed type. When the connection mechanism 166 is opened, it moves down to the position of the protruding connection mechanism 166b, and as shown in FIG. 7 (β) B, the money wall connection mechanism 166a is engaged with the protruding connection mechanism 166 | 3. , Close up and poke the bag

上移動,在上述藥品Μ留在上述槽容器13〇之後,上述空的袋容器抒 以第5圖箭頭(4)所示方向移動,由收集盒17〇收集。 "° 第8圖為上述重㈣測自動振動機構165的前視圖,上述自動振 動裝置165在注入上述藥品後以上述量侧單元164量測上述袋容哭又 1F的重量’當_到上述袋容器㈣内容物μ,根據上述訊號了 在某-段時間中運轉偏心凸輪165。,當上述偏心凸輸旋轉時,上述 線瘦163向上移動,而當上述偏心凸輪旋轉一圈時,運轉轴自上述偏 :凸輪165㈣最高點位置脫離,上述電·6扣而掉下,故上述 器1F以垂直方向振動,葬英卜、+、4 ^ 卜、fMH 動,附著在上述袋容器1F内側的 以σσ可以凡全的被振下來,亦可利用麼縮空氣向上述袋容哭Μ 的下以開π吹氣的方式來移除所有的殘餘藥品,如之後所述: 第9圖為上述起吊裝置16〇降低上述含有藥品_ ==人?剖面圖’上述既咖 := 述藥品_上述起吊裝置⑽降低,經過上述兩 固^腳職的,主入孔132到上述槽容器130内部,上述料斗167以四支 口疋腳167k固定在上述槽容器13〇的上側,而上述料斗⑻和 之間的縫隙以橡勝167g封裝封死以防上述藥品m四散,當上 =衣子聯至上述料斗167内部時,用來開關上述蓋子的 ―和上述袋容議底部相鄰,因此,原本打開的 2049-6929-PF;Ahddub 14 200533566 、 虛線所示則自動關上,以上述這個方法,上述藥品Μ因為上述阻隔蓋 167c關閉而不會四散,包含一彈簧的重量平衡器167b位於上述連鎖 控制桿167m的上部,而上述阻隔蓋167c在空的上述袋子1F被上述料 斗167懸掛後由上述重量平衡器167b打開。 用來切開上述袋子1F底部的切斷刀片167t位於上述料斗167的 下侧,上述切斷刀片167t為一不銹鋼三角形的刀體如上述圖中所 示,且上面具有銳利的邊緣,因此,當上述袋子1F被上述起吊裝置 160再降低時,上述袋子1F的下部和上述切斷刀片167t的上面相鄰, 而上述袋子1F被上述銳利刀片切開,當上述袋容器1F以上述這種方 ® 式被打開,上述袋容器1F中的上述藥品Μ透過位於上述料斗中下方的 藥品傳遞板167ρ縱向散播,且留在上述槽容器130的底部如第6中的 虛線所不。 當上述藥品Μ的注入完成時,上述重量偵測自動振動機構165會 自動被啟動,而殘餘的上述藥品Μ會被抖落,當上述自動振動機構165 停止時,上述壓縮空氣自位於下方的上述切斷刀片167t之氣體喷嘴 末端向上述空的袋子1F内側注入,如第9圖的虛線所示,因此殘留的 上述藥品Μ完全去除。 φ 上述空袋1F在上述藥品Μ完全拿出來後由上述起吊裝置160向上 提起,關閉的上述阻隔蓋167c在此時被固定在上述袋子1F上方的突 出連接器166b向上彈起而自動打開,接著,上述空袋1F由上述起吊 裝置160向第5圖和第6圖中的箭頭(4)方向傳送,如先前所述,並由 收集盒170收集,在此時,自上述袋子1F移除上述突出連接器166b 並重覆利用,上述袋子IF已經被切開,故不能再重覆使用而丟於工 業瘗料中。 重覆上述操作直到全數的上述藥品Μ(在這個實施例中為15)完 全被注入和保存,當上述操作結束時,所有運輸,清洗和注入上述 2049-6929-PF;Ahddub 15 200533566 和相同魏㈣枝備純勒錄態,衫全上述 槽容器⑽絲面以上料清洗方式料先水清 ’、’’以&固方法收集的上述清洗水中含有上述藥品Μ,上迄清洗 心㈣㈣填滿運送槽,未㈣圖中,以上述拖車⑽運送到用戶 4 ’亚作為在務後所述步驟咐,溶解上述藥品 步驟S2的工作。 氏较f兀成 X—所述纟上述第一藥品輸送方法中,從注入到保牟上述 藥,Μ的過程t,使科多裝置來避免上述藥品四散,纽財量到 可月b因上述藥口口 Μ而造成環境和安全度惡化的因素。 、、上述步驟S3中’上述槽容器130中的上述藥品㈣之前料,由 上述拖車1 00輸送到上述用戶的接收處180,上述槽容器㈣含約15 噸的上述藥品Μ,約30%的上述槽容器13〇的容量,上述第一藥品輪送 方法’可以-次運达大量粉狀的上述藥品Μ,因而改善輸送的效率, 因為上述藥品Μ不受溫度上升和下降的影響,故可以安全的輪返到遠 處寒冷處,關於用上述拖車100輸送上述藥品Μ,最好有一合格處理 危險藥品裝置的人員駕駛或參與以達上述的工作和成本效益。 上述步驟S4中,上述藥品Μ以拖車1〇〇運送至上述用戶藥品接收 處180,溶解在上述槽容器13〇中,第1〇圖為上述藥品Μ溶解的概要剖 面圖,顯示上述藥品Μ在用戶端提供溫水或蒸汽下,在上述槽容器13〇 中溶解,而溶解上述藥品Μ所得的藥品溶液被供應至上述用戶端的儲 存槽9。 裝載有上述槽容器130的拖車1〇〇停在上述用戶的藥品接收處 180(藥品溶解處)的既定位置,位於上述拖車用來保護勒之辅助 支持111固定於地上以支撐整個重量並吸收溶解時上述槽容器13〇產 生的振動,上述這樣的輔助支持lu是不可避免的,因為上述拖車1〇〇 的整個重量為約40噸,其中在上述藥品溶解後,包括供應於上述槽 2049-6929~PF;Ahddub 16 200533566 重’以及上述槽容器130 容益' 130的溫水約17噸重,上述藥品M趵丨5噸 自身的重量。 在溶解上述藥品Μ時,溶解時產生的蒸汽排出外面,連接到上述 粉塵收集濾器134f和上述外部排出風箱撕的上述排出管胸固定 在上述排出管固定口 134如以上所述,巾開始排出。 接者’上述槽容11130和上述藥品接受處18()之間的連接和傳送 透過用來注人溫水,提供蒸汽和循環的連㈣來執行,#完成上述 連接輸㈣’開啟在上述藥品接收處18_的閥門Bf(第_中桿號 為B的閥和在上述槽容器、⑽側的閥門Ba,而在上述槽容器剛: 的閥門Bb,Bc,Bd以及在上述藥品接收處18{)側的閥恤,此,此, Bi為關閉。 接著,設定在上述藥品接收處180側的流量計181為17噸,藉著 連接到位於上述槽容器13Q下側的排出σ137的的循環管線138^應 的溫水⑽至上述容器13G内部,(上述循環管線138在循環和混 合時y故為注入口 ’故留在上述槽容器130底部的上述藥μ可以早 先被溶解),供應至上述槽容器130溫水的量由上述液位偵測器⑶ 偵測,且由一控制單元所控制,未示於圖中。 m • 接著關閉閥門Ba,打開閥門肋,Bd,設定上述流量計181為1〇. 6 噸,+而溫水總量的60%由位於上述槽容器13〇上部和下部的循環管 的喷嘴135η注入上述槽容器13〇内部。 接著,連接上述獨立的發電機作能源供應,上述混合裝置 因此啟動,上述混合裝置133包括頭133h,上述頭具有和旋轉軸13心 旋轉方向相反方向延伸溝槽133g,上述旋轉軸1333是用來支撐上部 的螺旋槳(旋轉扇),如第11〇〇和11(6)圖所示,以及位於上述槽容 器130主體上以緊配上述頭133h的頂針,在剛開始時,上述藥品μ尚 未完全溶解,上述螺旋槳的反應力矩大,因此,上述混合裝置M3 2049-6929-PF;Ahddub 17 200533566 —的主體反向旋轉,而上述頭133h藉上述反轉溝槽133g向上移動,且 被鎖死在最上端的位置,上述旋轉軸133s隨著上述頭13此一起升 起’而上述轉軸133s的轴端自位於上述槽容器130底部表面的上述旋 轉軸133s保護工具133y來,故可以自由旋轉。在上述第一藥品輸送 方法中,上述槽容器130内部具有一混合裝置133如以上所述,然而, 上述混合裝置亦有可能由用戶提供,在上述這個安置中,上述槽容 器13 0的結構可以簡化。 接著 §罐定上述頭133h上升時,準備額外的4β 4噸的溫水,上 j溫水(92 C )總量的25%則另外加入,之後,用來清洗上述輸送用槽 容器130的清洗水,自上述藥品注入部分收集,並再利用,在先前^ 述的工作完全時,驅動上述混合裝置133的轉動軸13仏,轉動上述螺 旋槳133p,以開始溶解上述藥品μ。 、 首先開啟上述閥門Ba,Bb,糾口故之後,關閉上述閥⑽,由 W循環㈣182的運轉來執行循環和混合,因此,可達到縮短溶解 時間,因為上述藥品M(也就是t酸納)溶解並吸收熱,故上述溫水以 92C提供,然而,當在溶解時,液體的溫度低於3『c時,上述循产 =會停止,打開上述閥⑽,供應水蒸汽,因此,上述液體溫】 上升至少到30 C,然後再次執行混合。 當溶解完成,啟動自動濃度伯測裝置,未示於圖中,於制 上述溶液的濃度,當上述溶液的濃度沒有達到既定濃度時,打開1 述閥門Bf’供應缺乏的溫水,#完成溫水供應時,_上述閥⑽, 料啟動上述混合裝置133,並執行混合以達㈣均的溶液,以 :種方式準備上述所需藥品的濃度和數量,而完成步驟附整個工 作0 的儲中,如先前所述方式所準備的上述藥品供應至用户 2049-6929-PF;Ahddub 18 200533566 —产s、在先關閉上述閥門Bb,Bc並開啟上述閥門肋之後,啟動上述循 % H82’透過界線濾器183自上述槽容器1獅底部側供應溶液至 上述儲存槽9’以備紙幫浦的漂白,當上述溶液供應完成時,關閉上 述闕ΐ B 3 ’ B h ’打開上述閥門β b,B C,B f,而約10 0公升的水被提供 用來/月,上逑循環管線135和上述槽容器⑽,打開上述間門^,而 上述槽容器130内的清洗水經由位在上述槽容器130底部壁的排出口 137排出+ ’且被收集在收集盆中,未示於圖上,以上述這個方法,完 成上述藥品至上述儲存槽9的供應。 ^ > f者關閉所有的閥門,並移除用來供應温水的上述接頭c卜 在=之"4接+部分漏出的溶液由上料㈣㈣,用於下次溶解, =束之別所述的工作後,上述混合裝置133的頭i33h以反方向旋 轉,而上述混合裝置133的主體儲放在上述槽容器 停止上述風箱134b,縣r卜、f拉-s 、 ⑷’接者 上述的= 頭,收回保護上述軸的支樓⑴,以 樣的方式,上述所有的準備工作恢復到上述起始狀能… 效用如以上^ 成上述弟一樂品輸送方法帶來的運作和 為第據本發明之第2實施例的藥品輸送方彻 為弟一口輸迗方法)之工作程序示意圖, 交將 溶解成一既定濃度的溶液,且根據上—直=狀氯酸納 稍後所述,上述第二實施例包括藉約啊的^;、輪运方法儲存,如 應於溶劑,^合並計算上述藥品 ^上相品Μ,對 .以及輸送上述藥品Μ至上述用戶的:溶^也就是 送方法的過程敘述中,在上述習知藥品 ^ 上述弟二藥品輸 輸送方法中所用的相同元件將具有相同的參昭=在上述第-藥品 第-藥品輸送方法的元件以2〇〇多的對應編號表而對應於上述 如在上述第-藥品輸送方法中,上述第二藥:輸送方法中,槽 2049-6929-PF/Ahddub 19 200533566 , 容器230包括混合和溶解粉狀藥品的裝置’上述粉狀藥品溶解在溶劑 中以利用上述拖車200,運送到上述用戶的藥品接藥處280,而準備 上述藥品Μ成為一既定濃度的溶液並被運送到上述用戶的儲存槽9, 包括步驟1S,儲存含一既定重量的上述藥品Μ的袋子1F在上述儲存倉 庫2,步驟2S,打開含有上述藥品Μ的上述袋子1F,加入上述藥品Μ 至上述槽容器230並在運送至上述用戶的過程中,使上述藥品μ保持 在上述粉末狀,步驟3S,用上述拖車200運送在上述槽容器230中的 藥品Μ到上述用戶的藥品接收處280,步驟S4A,自位於上述用戶藥品 接收處280的上述溶劑保存溶解槽250供應溶劑至上述槽容器23〇内 •部,混合循環以溶解上述藥品Μ成一既定濃度的溶液,以及步驟5S, 供應在第S4A步驟中溶解的上述藥品Μ溶液到上述用戶的儲存槽9,在 上述這個方式中,上述第一藥品輸送方法和上述第二藥品輸送方法 除了第S4A步驟以外皆具有相同的架構,因此,敘述上述第二藥品運 送方法的主要為具有不同架構的第S4A步驟。 在上述第二藥品輸送方法中的上述拖車200,包括,像上述拖車 100,牽引機210,起落架220,槽容器230,而在連接狀態的總長不 大於16·5公尺,高度不大於3.8公尺,或重量不大於444頁。 ❿ 如第13(A),(Β),(C)圖所示,裝載在上述拖車2〇〇上的上述槽 容器230,第13(A)圖的剖面側視圖,第13(B)圖的平面圖,第3(C) 圖所示為由第3(A)圖Χ-Χ線所得之剖面側視圖,如以上圖示所示,雖 然上述槽容器230和上述槽容器130的外表相似,但上述槽容器230 的内部結構不同。 上述槽容器230包括,兩個注入口 232(上述入口 132具有一保護 蓋232C,故可開關)以自上側將上述藥品μ注入上述槽容器230内部, 混合裝置233以混合注入上述藥品Μ,導管架設口 234,以及超音波液 位偵測器239,如以上所述,上述混合器233被存放在上述槽容器230 2049-6929-PF;Ahddub 20 200533566 -中直到上述藥品Μ被傳送到上述用戶的接收處2 § 〇。 上述槽容器230的底壁中心具有一液體注入管24〇,一邊開口位 於上述底壁,而另-開口則自上述底壁懸出,如務後所述,溫水自 溫水保存溶解槽250透過上述液體注入口 240進入上述槽容器23〇,而 上述藥品Μ的溶劑自上述槽容器230的底部側邊加入,上述液體注入 管240在完成上述溶液之後,作為注入溶液到溫水保存溶解槽25〇, 而在上述藥品溶解程序完成後,作為排出清潔上述槽容器23〇的清潔 水排出管。 上述槽容器230的底壁中間具有二液體注入管241以水平並列的 方式排列,如第13(B)圖所示,上述液體注入管241的數目可以因需 $而減少或增加,連接管242連接上述液體注入管24丨的水平中心如 第13(B)圖所示,而上述液體注入管243的一開口端連接上述連接管 242,而另一開口端向下伸展,自位於上述槽容器底壁的向下排 出如第13(A)圖所示,如之後所述,自上述溫水保存溶解槽25〇,經 過上述、液體注入官243供應上述藥品溶劑至上述槽容器23〇的内部, 而自上述液體注入管241的兩個開口端排出,以進行循環和混合。 、牙、此之外上述槽谷裔230的底壁中間具有液體注入管244以縱 _向並列,上述液體注入管244的一開口端位於上述槽容器2期高度 (广上述整個冋度的一半)方向位置,而另一開口端自上述槽容器聊 勺f 土向下犬出如上述液體注入管243,如稍後所述,上述槽容器2別 P的上述某。口 /合液經過上述液體注入管排出,且輸送自上述溫 水保存循環槽250的底部到上述槽容器23〇内部内部做循環。 /收集清潔水的裝置位於上述槽容器23〇的環狀壁外表面上,而排 出系統包括,排出導管234d,粉塵收集濾器234土,以及連接在上述 排出導官固定口 234的排出風箱234b,上述這個結構和上述第一藥品 輸送方法的結構相同,參照第4圖,而因此省略說明。 2049-6929-PF;Ahddub 21 200533566 ^ 上述槽容器230的内部以和以上所述的方法設計,在步驟S1中儲 存的上述藥品Μ在步驟S2中保持為粉末狀,而上述藥品Μ在步驟S3中 被運送到上述用戶的藥品接收處280,在這個實施例中,上述28個袋 子1F(總重約28噸)含上述藥品Μ被懸掛裝置保存在上述槽容器230的 内部,如第一藥品輸送方法的步驟S2中所述,在上述這個方法中, 根據第二藥品輸送方法,上述第二藥品輸送方法可以一次輸送大量 的上述藥品Μ,較於上述第一藥品輸送方法更多的,因此,輸送的效 率更進一步的改善,因為上述藥品Μ不受溫度高低的影響,上述藥品 Μ可以在安全的狀態輸送到遠方寒冷的地方,因為第二藥品輸送方法 •的第S1步驟到第S3步驟和上述第一藥品輸送方法相同,將省略說明。 在步驟S4A中,被拖車200輸送到上述用戶藥品接收處280的上述 藥品Μ,在供應端的槽容器230和用戶端的溫水保存溶解槽250之間混 合和循環,並溶解成既定濃度的溶液。 在準備上述藥品Μ的溶劑時,如第14圖所示,上述拖車200停在 上述用戶藥品接收處280的既定位置,四個位於上拖車200的起落架 220上,用來保護上述軸的輔助支撐221接地,而固定上述拖車200, 上述藥品接收處280(或鄰近處)具有溫水保存溶解槽250以及儲存藥 φ品溶液的儲存槽9,上述用戶事先存放32噸(32m3)的90°C溫水於上述 溫水保存溶解槽250。 接著,為了釋放溶解時產生的蒸汽到外面,連接上述粉塵接收 濾器234f和上述外部排出風箱234b的排出導管234d連接上述導管固 定口 234,然後,驅動獨立能源的馬達,而放置在上述拖車230内部 的上述混合裝置233向上移動。 再來,執行上述槽容器230和上述溫水保存溶解槽250之間的輸 送和連接,第15圖為自上述槽容器230側邊和上述溫水保存溶解槽 2 5 0側邊的剖面圖,如以上圖示所示,位於上述溫水保存溶解槽2 5 0 2049-6929-PF;Ahddub 22 200533566 ,底壁的液體注入管251,252,而液體注入管253外位於上述溫水保 溶解槽25G的側壁以分開向外排出,上述液體注入管挪和上述液體 注入管252在中點連接,並組成液體注入管254,而兩個液體注入管 255, 256在上述液體注入管254的中點分支並連接,上述液體注入^ 2M的開口連接上述儲存槽9,液體注入幫浦pb和上述閥門位於上 述液體注入管251的中點,上述閥門Ba位於上述液體注入管252上, 上述閥門Bd位於上述液體注入管253上,液體注入幫浦以和上述閥門 Be位於上述液體注入管254上,上述閥門此位於上述液體注入管託$ 上,上述閥門Bb位於上述液體注入管256上,分別地,如之後所述, 馨用來讓上述藥品溶液擴散的碟狀阻擋板257位於連接在上述溫水保 存溶解槽250底壁的上述液體注入管251的開口些微上方,上_ 設備位於上述用戶端。 則 在上述管線傳送系統中,上述槽容器23〇和上述溫水保存溶解槽 250之間的傳輸和連接,藉著分別連接上述溫水保存溶解槽25〇側^ 上述液體注入管251,255,256,透過連接裝置244c,243c,24〇c, 連接上述槽容器230側壁的上述液體注入管244,243,24〇來達成, 在這個安置中,完成溶解上述藥品M的準備工作,上述分別的準備工 ❿作沒有優先順序,可以按照情況執行順序,亦可以在人力許可的情 形下同時執行。 當上述準備工作完成,在上述温水保存溶解槽2 5 〇的溫水注入上 述槽容器230内部’而開始上述藥品]^|的溶解。 藉著打開上述閥’,Bb,啟動上述液體注入幫浦㈣執行液 體注入(關閉其他的閥門,和液體注入幫浦),而如第16圖所示,注 入32嘲中的㈣的溫水自上述溫水保存溶解槽25(),透過上述液體注 入管252, 254, 256, 240,傳送到上述槽容器23〇内部,在這個時候, 傳送到上述槽容器230内部的上述溫水的總量由位在上述槽容器23〇 2049-6929-PF;Ahddub 200533566 •上的起音波液位偵測器239所偵測,且由未示於圖示的控制單元所控 制,亦可以用流量計來取代上述的超音波液位偵測器239,因為上述 溫水由上述槽容器230底壁中心以向上散開的方式供應,如圖所示, 在上述槽容鉍230的上述粉狀藥品μ因此自上述底壁以碗狀溶解。 接著,分止上述液體注入幫浦?&並關閉上述閥門如,Bb,第17 圖所示狀態,以及在這個時候,關閉所有的閥門和傳輸系統和所有 液體注入幫浦,另一方面,剩餘未溶解的上述藥品M將在上述混合裝 置233的混合過程中,由13噸的溫水溶解成最大量(最大濃度: 50·2%)。 又 _ 接著,打開上述閥HBc,Bd,Bf並啟動上述液體注入幫浦pa,After the medicine M is left in the tank container 13o, the empty bag container is moved in the direction shown by the arrow (4) in Fig. 5 and collected by the collection box 17o. " ° FIG. 8 is a front view of the heavy measuring automatic vibration mechanism 165. The automatic vibration device 165 measures the weight of the bag volume and 1F with the measuring side unit 164 after the medicine is injected. The contents of the bag container μ are based on the above signals, and the eccentric cam 165 is operated for a certain period of time. When the eccentric convex rotation rotates, the line thin 163 moves upward, and when the eccentric cam rotates once, the running shaft is detached from the highest point of the eccentric cam 165㈣, and the electric · 6 buckle falls, so the above The device 1F vibrates in the vertical direction, and the buoys, +, 4 ^, and fMH move. The σσ attached to the inside of the above-mentioned bag container 1F can be shaken down in all directions, or the air can be used to cry to the above-mentioned bag capacity. To remove all the remaining medicines, open the π blow, as described later: Figure 9 shows the lifting device 16 above, reducing the above-mentioned medicines _ == people? Sectional view 'The above-mentioned coffee: = Said medicine _ The lifting device ⑽ is lowered, and after passing through the two fixed feet, the main entry hole 132 is inside the tank container 130, and the hopper 167 is fixed to the above with four mouths 167k. The upper side of the tank container 13〇, and the gap between the hopper and the hopper is sealed with 167g of rubber to prevent the medicines from scattered. When the upper garment is connected to the inside of the hopper 167, it is used to open and close the lid--and The bottom of the bag is adjacent, so the originally opened 2049-6929-PF; Ahddub 14 200533566 and the dotted line are closed automatically. In this way, the medicine M will not be scattered because the barrier lid 167c is closed. A spring weight balancer 167b is located on the upper part of the chain control lever 167m, and the blocking cover 167c is opened by the weight balancer 167b after the empty bag 1F is suspended by the hopper 167. The cutting blade 167t for cutting the bottom of the bag 1F is located on the lower side of the hopper 167. The cutting blade 167t is a stainless steel triangular blade as shown in the figure above, and has a sharp edge on the top. Therefore, when the above When the bag 1F is lowered by the lifting device 160 again, the lower part of the bag 1F is adjacent to the upper surface of the cutting blade 167t, and the bag 1F is cut by the sharp blade. When the bag container 1F is When opened, the medicine M in the bag container 1F is spread longitudinally through the medicine transfer plate 167ρ located in the lower part of the hopper, and the bottom of the groove container 130 is left as shown by the dotted line in FIG. 6. When the injection of the medicine M is completed, the weight detection automatic vibration mechanism 165 will be automatically activated, and the remaining medicine M will be shaken off. When the automatic vibration mechanism 165 is stopped, the compressed air from the below-mentioned The end of the gas nozzle of the cutting blade 167t is injected into the inside of the empty bag 1F, as shown by the dotted line in FIG. 9, so the remaining medicine M is completely removed. φ The empty bag 1F is lifted up by the lifting device 160 after the medicine M is completely taken out, and the closed blocking cover 167c is now lifted upward by the protruding connector 166b fixed above the bag 1F, and then automatically opens, then The empty bag 1F is transferred by the lifting device 160 in the direction of the arrow (4) in FIG. 5 and FIG. 6 as described above and collected by the collection box 170. At this time, the above is removed from the bag 1F The connector 166b is protruded and reused. The above-mentioned bag IF has been cut, so it cannot be reused and lost in industrial materials. Repeat the above operation until all of the above-mentioned medicine M (15 in this embodiment) is completely injected and stored. When the above operation is completed, all transportation, cleaning and injection of the above 2049-6929-PF; Ahddub 15 200533566 and the same Wei The stalks are prepared in a purely recorded state, and all the above tanks are cleaned. The cleaning method of the silk surface is to be cleaned first. The above-mentioned washing water collected by the & solid method contains the above-mentioned drug M. The transport tank, not shown in the figure, uses the above-mentioned trailer ⑽ to transport to the user 4 ′ ya as a step described in the post-service order to dissolve the medicine in step S2. In the first drug delivery method described above, the process from injection to guaranty the above-mentioned drugs, the process t, so that the Kodo device to avoid the above-mentioned drugs scattered, the amount of money to the month can be b due to the above The factors that cause the deterioration of the environment and safety due to the drug mouth. In the above step S3, the aforementioned medicines in the above-mentioned tank container 130 are transported by the trailer 100 to the receiving place 180 of the user, and the above-mentioned tank container contains about 15 tons of the above-mentioned medicine M, about 30%. With the capacity of the tank container 130, the first medicine rotation method can transport a large number of the powdered medicines M in one pass, thereby improving the efficiency of transportation, because the medicines M are not affected by temperature rise and fall, so It is safe to return to a distant cold place. Regarding the transportation of the above-mentioned medicine M by the above-mentioned trailer 100, it is better to have a person qualified to deal with the dangerous medicine device to drive or participate to achieve the above-mentioned work and cost-effectiveness. In step S4, the medicine M is transported to the user medicine receiving place 180 in a trailer 100 and dissolved in the tank container 13. FIG. 10 is a schematic cross-sectional view of the dissolution of the medicine M, showing that the medicine M is in The warm water or steam provided by the user side dissolves in the tank container 13 and the medicine solution obtained by dissolving the medicine M is supplied to the storage tank 9 of the user side. The trailer 100 loaded with the tank container 130 is parked at a predetermined position of the medicine receiving place 180 (medicine dissolving place) of the user, and is located on the ground to support the auxiliary support 111 fixed to the ground to support the entire weight and absorb dissolution. At the time of the vibration generated by the tank container 13 above, the above-mentioned auxiliary support lu is inevitable, because the entire weight of the trailer 100 is about 40 tons, and after the medicine is dissolved, it includes supply to the tank 2049-6929. ~ PF; Ahddub 16 200533566 weight, and the above-mentioned tank container 130 Rongyi's 130 warm water weighs about 17 tons, and the above-mentioned medicine M 趵 丨 5 tons own weight. When dissolving the medicine M, the steam generated during the dissolution is discharged to the outside. The discharge tube chest connected to the dust collection filter 134f and the external discharge bellows is fixed to the discharge pipe fixing port 134. As described above, the towel starts to be discharged. . The user's connection and transmission between the above-mentioned tank capacity 11130 and the above-mentioned medicine receiving place 18 () are performed through the flail used for injecting warm water, providing steam and circulation. #Complete the above-mentioned connection and input. ' Receiving place 18_ valve Bf (the valve of the _ middle rod B and the above-mentioned tank container, the valve Ba on the side, and in the above-mentioned tank container: the valves Bb, Bc, Bd, and at the above-mentioned medicine receiving section 18 {} Side of the valve shirt, so, this, Bi is closed. Next, the flow meter 181 on the 180 side of the medicine receiving place is set at 17 tons, and the warm water corresponding to the circulation line 138 of the discharge sigma 137 located below the tank container 13Q is poured into the container 13G, ( The circulation line 138 is an injection port during circulation and mixing. Therefore, the medicine μ remaining at the bottom of the tank container 130 can be dissolved earlier. The amount of warm water supplied to the tank container 130 is determined by the liquid level detector. ⑶ Detected and controlled by a control unit, not shown in the figure. m • Then close the valve Ba, open the valve rib, Bd, set the above flow meter 181 to 10.6 tons, and 60% of the total amount of warm water is from the nozzle 135η of the circulation pipe located above and below the tank container 130. Fill into the tank container 130. Next, the independent generator is connected for energy supply, so the mixing device is started. The mixing device 133 includes a head 133h, the head has a groove 133g extending in a direction opposite to the rotation direction of the 13-axis rotation axis, and the rotation shaft 1333 is used for The propeller (rotating fan) supporting the upper part, as shown in Figures 1100 and 11 (6), and a thimble located on the main body of the tank 130 to fit tightly with the head 133h, at the beginning, the medicine μ has not been completely Dissolved, the reaction torque of the propeller is large, so the main body of the mixing device M3 2049-6929-PF; Ahddub 17 200533566 — rotates in the reverse direction, and the head 133h moves upwards through the reverse groove 133g and is locked in place. At the uppermost position, the rotation shaft 133s is raised together with the head 13, and the shaft end of the rotation shaft 133s comes from the protection tool 133y of the rotation shaft 133s located on the bottom surface of the tank container 130, so it can rotate freely. In the first medicine delivery method, the tank container 130 has a mixing device 133 as described above. However, the mixing device may be provided by the user. In the above arrangement, the structure of the tank container 130 may be simplify. Then § when the head is raised 133h, an additional 4β of 4 tons of warm water is prepared. 25% of the total amount of warm water (92 C) is added separately. After that, it is used to clean the transport tank container 130. Water is collected from the medicine injection part and reused. When the previous work is completed, the rotating shaft 13 仏 of the mixing device 133 is driven and the propeller 133p is rotated to start dissolving the medicine μ. 1. First open the above valves Ba and Bb. After correcting the problem, close the above valve ⑽ and perform circulation and mixing by the operation of W cycle ㈣ 182. Therefore, the dissolution time can be shortened because the above-mentioned drug M (that is, t acid sodium) Dissolve and absorb heat, so the above warm water is provided at 92C. However, when the temperature of the liquid is lower than 3 "c during dissolution, the above-mentioned production cycle will stop, open the valve ⑽, and supply water vapor. Therefore, the above liquid Body temperature] Raise to at least 30 C, then perform mixing again. When the dissolution is completed, start the automatic concentration measurement device, not shown in the figure, to make the concentration of the above solution. When the concentration of the above solution does not reach the predetermined concentration, open the valve Bf 'to supply the lack of warm water. When water is supplied, the above valve will start the above mixing device 133 and perform mixing to achieve a homogeneous solution. Prepare the concentration and quantity of the above-mentioned required drugs in one way, and complete the steps with the entire work in the storage of 0 The above-mentioned medicines prepared in the manner described above are supplied to users 2049-6929-PF; Ahddub 18 200533566 — produced, after the valves Bb, Bc are closed first and the valve ribs are opened, the above-mentioned cycle% H82 'is passed through the boundary line. The filter 183 supplies the solution from the bottom of the tank container 1 to the storage tank 9 'to prepare the paper pump for bleaching. When the supply of the solution is completed, close the 阙 ΐ B 3' B h 'and open the valve β b, BC , B f, and about 100 liters of water is provided for / month, the upper circulation line 135 and the above tank container ⑽, the above door ^ is opened, and the washing water in the above tank container 130 is located in the above tank The bottom wall of the discharge outlet 130 discharging + 137 'and is collected in a collection basin, not shown in the figure, the above-described methods, these drugs to complete the storage tank 9 is supplied. ^ > f close all the valves, and remove the above-mentioned joints used to supply warm water c == " 4 + + part of the leaked solution from the feed ㈣㈣, for the next dissolution, = Shuzhi elsewhere After the work described above, the head i33h of the mixing device 133 rotates in the opposite direction, and the main body of the mixing device 133 is stored in the tank container to stop the bellows 134b. == head, take back the branch to protect the shaft, in the same way, all the above preparations are restored to the above-mentioned initial energy ... the effect is as above According to the second embodiment of the present invention, the drug delivery method is a schematic diagram of the working procedure of the child's mouth, and will be dissolved into a solution of a predetermined concentration. The second embodiment includes ^ borrowing; storage by rotation method, if it should be in the solvent, ^ combined calculation of the above medicine ^ upper product M, right. And delivery of the above medicine M to the above user: solvent ^ is also sent The process is described in the above known Products ^ The same components used in the above-mentioned second drug delivery method will have the same reference = the components in the above-mentioned first-drug-drug delivery method will have more than 2,000 corresponding number tables corresponding to the above as described in the above-mentioned first -In the medicine conveying method, the above-mentioned second medicine: in the conveying method, the tank 2049-6929-PF / Ahddub 19 200533566, and the container 230 includes a device for mixing and dissolving the powdered medicine. 'The powdered medicine is dissolved in a solvent to use the trailer. 200. The medicine is delivered to the medicine receiving place 280 of the user, and the medicine M is prepared into a solution of a predetermined concentration and is delivered to the storage tank 9 of the user, including step 1S, which stores a bag containing the medicine M of a predetermined weight. 1F In the storage warehouse 2 and step 2S, open the bag 1F containing the medicine M, add the medicine M to the tank container 230, and keep the medicine μ in the powder form during transportation to the user. 3S, use the trailer 200 to transport the medicine M in the tank container 230 to the medicine receiving place 280 of the user, and in step S4A, pick up the medicine from the user The solvent storage dissolution tank 250 at 280 supplies the solvent to the inside of the tank container 230, and mixes and circulates to dissolve the drug M into a solution of a predetermined concentration, and step 5S supplies the solution of the drug M dissolved in step S4A. To the storage tank 9 of the user, in the above method, the first medicine transportation method and the second medicine transportation method have the same structure except for step S4A. Therefore, the main description of the second medicine transportation method is Step S4A with different architecture. The trailer 200 in the second medicine delivery method includes, like the trailer 100, the tractor 210, the landing gear 220, and the tank container 230, and the total length in the connected state is not more than 16.5 meters and the height is not more than 3.8 Meters, or weight not more than 444 pages. ❿ As shown in Figures 13 (A), (B), and (C), the tank container 230 loaded on the trailer 2000, a sectional side view of Figure 13 (A), and Figure 13 (B) Fig. 3 (C) shows a cross-sectional side view taken from the line XXX of Fig. 3 (A). As shown in the figure above, although the appearance of the above-mentioned tank container 230 and the above-mentioned tank container 130 are similar, However, the internal structure of the tank container 230 is different. The tank container 230 includes two injection ports 232 (the inlet 132 has a protective cover 232C, so it can be opened and closed) to inject the medicine μ into the tank container 230 from the upper side, and a mixing device 233 for injecting the medicine M into the tank. The erection port 234 and the ultrasonic liquid level detector 239, as described above, the mixer 233 is stored in the tank container 230 2049-6929-PF; Ahddub 20 200533566-until the medicine M is transmitted to the user Recipients 2 § 〇. The bottom wall of the tank container 230 has a liquid injection tube 24 in the center, and one opening is located on the bottom wall, and the other opening is suspended from the bottom wall. As described later, warm water is kept from the warm water to dissolve the tank 250. Enter the tank container 23 through the liquid injection port 240, and the solvent of the medicine M is added from the bottom side of the tank container 230. After the liquid injection tube 240 completes the solution, it is injected into the warm water to dissolve the solution in the tank. 25〇, and after the above-mentioned drug dissolution process is completed, as a clean water drain pipe for cleaning the tank container 23〇. In the bottom wall of the tank container 230, two liquid injection pipes 241 are arranged side by side in a horizontal manner. As shown in FIG. 13 (B), the number of the liquid injection pipes 241 can be reduced or increased as needed. The horizontal center connecting the liquid injection pipe 24 丨 is shown in FIG. 13 (B), and one open end of the liquid injection pipe 243 is connected to the connection pipe 242, while the other open end extends downward, and is located in the tank container. The downward discharge of the bottom wall is as shown in FIG. 13 (A). As described later, the dissolution tank 25o is stored from the warm water, and the chemical solvent is supplied to the inside of the tank container 23o through the liquid injection unit 243. And discharged from the two open ends of the liquid injection pipe 241 for circulation and mixing. In addition, there is a liquid injection pipe 244 juxtaposed in the middle of the bottom wall of the trough valley 230. One of the open ends of the liquid injection pipe 244 is located at the height of the second stage of the trough container (half of the entire length of the entire cavity). ) Position, and the other open end is from the above-mentioned tank container, the soil injection pipe downwards out of the above-mentioned liquid injection pipe 243, as described later, the above-mentioned tank container 2 does not have one of the above. The mouth / fluid is discharged through the liquid injection pipe, and is conveyed from the bottom of the warm water storage circulation tank 250 to the inside of the tank container 23o for circulation. The device for collecting clean water is located on the outer surface of the annular wall of the above-mentioned tank container 23, and the discharge system includes a discharge duct 234d, a dust collection filter 234, and a discharge wind box 234b connected to the discharge guide fixing port 234. The above-mentioned structure is the same as the structure of the first medicine delivery method. Referring to FIG. 4, the description is omitted. 2049-6929-PF; Ahddub 21 200533566 ^ The inside of the above tank container 230 is designed in the same manner as described above. The medicine M stored in step S1 is kept in a powder form in step S2, and the medicine M is stored in step S3. It is transported to the medicine receiving place 280 of the above user. In this embodiment, the 28 bags 1F (about 28 tons in total) containing the medicines M are stored in the tank container 230 by the hanging device, such as the first medicine. As described in step S2 of the conveying method, in the above method, according to the second medicine conveying method, the second medicine conveying method can convey a large amount of the medicines M at a time, which is more than the first medicine conveying method, so The delivery efficiency is further improved, because the above-mentioned medicine M is not affected by the temperature, and the above-mentioned medicine M can be transported to a distant cold place in a safe state, because the second medicine transportation method • steps S1 to S3 This is the same as the above-mentioned first medicine delivery method, and description thereof will be omitted. In step S4A, the medicine M transported by the trailer 200 to the user medicine receiving place 280 is mixed and circulated between the tank container 230 on the supply side and the warm water storage dissolution tank 250 on the user side, and dissolved into a solution of a predetermined concentration. When preparing the solvent for the medicine M, as shown in FIG. 14, the trailer 200 is parked at a predetermined position of the user's medicine receiving place 280, and four are located on the landing gear 220 of the upper trailer 200 to protect the auxiliary shaft. The support 221 is grounded, and the trailer 200 is fixed. The medicine receiving place 280 (or nearby) has a warm water storage dissolution tank 250 and a medicine storage solution 9 storage tank. The user stores 32 tons (32m3) of 90 ° in advance. C. Warm water is stored in the dissolution tank 250 in the warm water. Next, in order to release the steam generated during dissolution to the outside, an exhaust duct 234d connecting the dust receiving filter 234f and the external exhaust air box 234b is connected to the duct fixing port 234, and then an independent energy motor is driven and placed in the trailer 230. The above-mentioned mixing device 233 inside moves upward. Next, the transportation and connection between the tank container 230 and the warm water storage dissolution tank 250 are performed. FIG. 15 is a cross-sectional view from the side of the tank container 230 and the warm water storage dissolution tank 250 side. As shown in the figure above, the hot water storage dissolution tank 2 5 0 2049-6929-PF; Ahddub 22 200533566 has liquid injection tubes 251 and 252 on the bottom wall, and the liquid injection tube 253 is located outside the 25G The side wall is discharged outwards separately. The liquid injection pipe and the liquid injection pipe 252 are connected at a midpoint and form a liquid injection pipe 254. The two liquid injection pipes 255, 256 branch and merge at the midpoint of the liquid injection pipe 254. Connection, the liquid injection opening 2M is connected to the storage tank 9, the liquid injection pump pb and the valve are located at the midpoint of the liquid injection pipe 251, the valve Ba is located on the liquid injection pipe 252, and the valve Bd is located on the liquid On the injection pipe 253, the liquid injection pump and the valve Be are located on the liquid injection pipe 254, the valve is located on the liquid injection pipe holder, and the valve Bb is located on the liquid injection pipe. On the tube 256, respectively, as will be described later, the dish-shaped blocking plate 257 used by Xin to diffuse the drug solution is located slightly above the opening of the liquid injection tube 251 connected to the bottom wall of the warm water storage and dissolution tank 250. _ The device is located at the above client. Then, in the pipeline conveying system, the transmission and connection between the tank container 23o and the warm water storage and dissolution tank 250 are respectively connected by the warm water storage and dissolution tank 25o side ^ the liquid injection pipes 251, 255, 256. This is achieved through the connecting devices 244c, 243c, and 24oc, which are connected to the liquid injection pipes 244, 243, and 24o on the side wall of the tank container 230. In this arrangement, the preparation for dissolving the drug M is completed. There is no order of priority for preparation work, and the order can be performed according to the situation or at the same time with the permission of manpower. When the above preparations are completed, the warm water in the warm water storage dissolution tank 250 is poured into the inside of the tank container 230 'to start dissolution of the medicine] ^ |. By opening the above valve ', Bb, the above-mentioned liquid injection pump ㈣ is started to perform liquid injection (the other valves are closed, and the liquid injection pump), and as shown in FIG. The warm water storage dissolution tank 25 () is transmitted to the inside of the tank container 23 through the liquid injection pipes 252, 254, 256, 240, and at this time, the total amount of the warm water transmitted to the inside of the tank container 230 It is detected by the attack wave level detector 239 on the tank container 23〇2049-6929-PF; Ahddub 200533566, and is controlled by a control unit (not shown). It can also be flowmetered. Instead of the above-mentioned ultrasonic liquid level detector 239, since the warm water is supplied upward from the center of the bottom wall of the tank container 230, as shown in the figure, the powdered medicine μ in the tank capacity Bismuth 230 therefore The bottom wall is dissolved in a bowl shape. Then, stop the above-mentioned liquid injection pump? & Close the above valves as shown in Bb, Figure 17, and at this time, close all valves and delivery systems and all liquid injection pumps, on the other hand, the remaining undissolved drug M will be in the above During the mixing process of the mixing device 233, 13 tons of warm water was dissolved to a maximum amount (maximum concentration: 50 · 2%). _ Next, open the valves HBc, Bd, Bf and start the liquid injection pump pa,

Pb,因此,如第18圖所示,上述藥品溶液在上述槽容器23〇 水保存溶解槽250之間循環和混合,在這個時候,f = 打開上述液體注入管線244,也就是,位於上述槽容一= 度的吸口’未溶解自沈積在上述槽容器23_部底侧的上述粉狀藥品 Μ沒有被上述液體注入幫浦Pb吸入,而僅有高濃度的溶液被吸入,高 濃度溶液自上述溫水保存溶解槽250的底部,透過上述液體注入管 244,251,供應至上述溫水保存溶解槽25〇内部,接著,上述高濃度 馨溶液藉由位於排出口向上傾斜的緩衝板257在底壁水平擴散,經由上 述這個擴散操作,分離位於上層的溫水和位於下層的上述高濃度溶 液,而僅有位於上層的溫水被位於下層的上述高濃度溶液向上推 擠,而經由上述液體注入管253運送,在這個時候,上述上述液體注 入幫浦Pa,Pb由上述液位偵測器239偵測,並由未示於圖中的控制單 元控制而保持上述槽容器230的液位一定。 在這個時候,因為上述高濃度溶液在上述溫水保存溶解槽25〇 中的特定重力為1.4的等級,而比上述溫水重,而當上述溫水的溫度 為90°C時,上述高濃度溶液的溫度約為⑽艺到如它,上述兩者並沒 2049-6929-PF;Ahddub 24 200533566 有完=合’如第酬所示,故上述位於上層的溫水和位於下 上述咼派度溶液的狀態依然繼續,如上述圖示所示,上 官253的一開口端,也就是溫水的吸口的位置位於上述u噸溫水水位 的較下方處,只有在上述上層的溫水經過上述液體注入管2^,, 255, 243, 241供應到上述槽容器23◦,故位於底部尚未^容解 上述藥品Μ有效的被溶解,藉著重覆這樣的溶解運作,執行上述=環 和混合,而最後,位於上述槽容器2_部的上述藥品μ完全、:衣 ^立於上述槽容器2_部和位於上述溫水保留和溶解槽挪内 洛液具有均勻的濃度。 接著,操作員停止上述液體注入幫浦Pa,,關閉上述閥門Β。, Bd和Μ,並㈣上述_Ba,細使上述液體注人幫浦%反轉,因 此’如第_的箭頭所示,上述槽容器23()内部全部的上述溶液被傳 =到上述溫水保存溶解槽250内部,因為此時的液體濃度為後⑽, 乂所需的產品濃度46%高-點,供應額外的G. 87β頓的溫水至上述溫水 保存岭解槽25G,啟動事先位於上述溫水保留和溶解槽25〇内的混合 裳置258以微調最後的濃度,在步S2驟中收集的溶液為上述〇㈣的 溫水部分以上述方法加人而再利用,以上述這個方式,如第則所 不,在上述溫水保留和溶解槽25〇中調整6〇·8噸的46%的溶液,而完 成上述步驟S4的整個工作。 在步驟S5巾’如以上所述方法所準備的溶液被供應到上述儲存 槽9中,在注入溶液時,關閉上述間門此士,触^而打開上述 ,門Ba,Be,而上述液體注人幫浦pa,pb以—般旋轉方式運轉,如 第20圖中的箭頭所示’上述溫水保留和溶解槽25()中的所有溶液傳送 到上述儲存槽9’儲雜上述儲存槽9的上述藥品M溶液用於紙裝的漂 白。 接著,停止所有驅㈣統,_所有上述關,而移除所有連 2〇49-6929-PF;Ahddub 25 200533566 . 接器240c,243c,244c,故分開所有位於上述槽容器230和上述溫水 保存溶解槽250之間的輸送系統,自上述連接器漏出的上述溶液在上 述清潔水和漏出液體收集盤中累積,收集至下次溶解中再利用,在 停止上述驅動系統前,反轉位於上述槽容器230的混合裝置233,接 著收起用來保護軸的上述支架221,上述所有的準備工作恢復到上述 起始狀態,而完成上述步驟S5的所有工作。 如以上所述細節,上述第二藥品輸送方法中,在上述供應端的 上述上述槽容器230和上述使用端的上述温水保留和溶解槽250之 間,執行上述粉狀藥品的混合和循環,在短時間内可以準備大量的 ®藥品溶液,而大量的減少成本。 在上述粉狀藥品溶解或促進溶解期間,預防溫水溫度降低,最 好供應水蒸汽至上述槽容器230,而因此最好事先在用戶端具有水蒸 汽供應設備。 [工業應用] 僅管在述敘本發明所有的上述實施例之粉狀藥品為氯酸鈉,本 發明並不僅限於上述藥品的輸送,而可有效應用於溶於溶劑的粉狀 藥品的輸送,特別是關於,特別是關於在儲存,輸送,溶解和運送 φ 的處理需要安全無害的粉狀危險藥品。 【圖式簡單說明】 第1圖係為根據本發明的第一藥品輸送方法流程概要圖; 第2圖係為用於藥品輸送拖車的側視圖; 第3圖係為裝載在上述拖車之槽容器的内部結構圖,其中(A)為 側視剖面圖,(B)為平面圖,(C)為(A)圖中X-X線的剖面圖; 第4圖係為上述槽容器外表的立體圖; 第5圖係為注入上述藥品至上述槽容器並由起重裝置支持的平 2049-6929-PF;Ahddub 26 200533566 面圖 第6圖係為第5圖的側視圖; 中⑴第 為用來連接和拆卸藥品保存袋之連接機構的前視圖,苴 中(Α)為固疋前的狀態,(Β)為固定後的狀態; 、 f8圖係為重量偵測自動搖晃機構的前視圖; 第9圖係為藥品保持袋打開狀態時的剖面圖; ΐ = 槽容器在藥品接收處的側視圖(藥品溶解室); 弟Π圖係為合裝置結構的剖面圖,其 體固定的狀態,(β)為上升狀能· 巧述犯口表置主 視面")為(:::=广-側 :圖係為上述槽容器在藥品接收處的側視圖; 弟15圖係為上述槽容器和 剖面圖; j保存々解槽之間傳輸管線系統的 第16圖係為自上述溶劑保存溶、 態之剖面側視圖; 寻、恤水到上述槽容器的狀 第17圖係為上述藥品在上述样 圖; 9 σ内°卩溶解狀態的剖面側視 第18圖係為藥品溶液在上述样 和混合狀態的側視剖面圖; ㈢^溶劑保存溶解槽之間循環 第19圖係為上述溶劑保存溶解槽收 第20圖係為傳送已準備好具 吻、柰叩岭液狀悲的剖面圖’· 圖 、疋’辰度的藥品溶液狀態之剖面 第21圖係為習知技術之藥 第22圖係為另—f知技法流程概要圖;以及 技奴樂品輸送方m概要圖。 2049-6929-PF;Ahddub 200533566 【主要元件符號說明】 1〜藥品容器; 3〜輸送用卡車; 9〜健存槽; 10〜拖車; 12〜起重裝置; 10 0〜拖車; 120〜起重裝置; 131〜圓周壁; 133〜混合裝置; 135〜循環管線; 139〜液位偵測器; 170〜收集盒; 2 0 0〜拖車; 220〜起重裝置; 231〜圓周壁; 233〜混合裝置; 239〜液位偵測器; 280〜藥品接收處。 1F〜袋子; 2〜危險藥品儲存倉庫(供應端); 4危險藥品儲存倉庫(用戶端 11〜牽引機; ’ 13〜槽容器; 110〜牽引機; 130〜槽容器; 132〜注入口; 134〜導管固定口; 137〜排出口; 160〜起重裝置; 180〜藥品接收處; 210〜牽引機; 230〜槽容器; 2 3 2〜注入口; 234〜導管固定口; 250〜溫水保存溶解槽; 2049-6929~PF;AhddubPb. Therefore, as shown in FIG. 18, the drug solution is circulated and mixed between the tank container 23 and the water storage dissolution tank 250. At this time, f = the liquid injection line 244 is opened, that is, located in the tank. Rongyi = degree of suction mouth 'undissolved from the powder medicine M deposited on the bottom side of the tank container 23_ is not sucked by the liquid injection pump Pb, but only a high concentration solution is sucked, The bottom of the warm water storage and dissolution tank 250 is supplied to the inside of the warm water storage and dissolution tank 25 through the liquid injection pipes 244 and 251, and then, the high-concentration Xinxin solution is placed in the buffer plate 257 inclined upward at the discharge port. The bottom wall diffuses horizontally. Through this diffusion operation, the warm water in the upper layer and the high-concentration solution in the lower layer are separated. Only the warm water in the upper layer is pushed upward by the high-concentration solution in the lower layer, and passes through the liquid. The injection pipe 253 is transported. At this time, the above-mentioned liquid is injected into the pump Pa, Pb is detected by the above-mentioned liquid level detector 239, and is controlled by a control unit not shown in the figure. The control groove while holding the container 230 in a certain level. At this time, because the specific gravity of the high-concentration solution in the warm-water storage and dissolution tank 25o is a level of 1.4, it is heavier than the warm-water, and when the temperature of the warm-water is 90 ° C, the high-concentration The temperature of the solution is about the same as it is, and the above two are not 2049-6929-PF; Ahddub 24 200533566 is finished = as shown in the paragraph, so the warm water in the upper layer and the lower degree in the above The state of the solution still continues. As shown in the figure above, an open end of Shangguan 253, that is, the position of the suction of warm water is located below the u-ton warm water level. Only the warm water in the upper layer passes through the liquid. The injection tubes 2 ^ ,, 255, 243, 241 are supplied to the above-mentioned tank container 23, so the medicine M at the bottom has not yet been lysed, and the above-mentioned medicine M has been effectively dissolved. By repeating such a dissolution operation, the above-mentioned loop and mixing are performed, and Finally, the medicine μ located in the 2nd part of the tank container is completely complete, and the clothes are standing in the 2nd part of the tank container and in the warm water holding and dissolving tank. Next, the operator stops the liquid injection pump Pa and closes the valve B. , Bd and M, and the above _Ba, finely reverse the liquid injection pump%, so 'as indicated by the _ arrow, all the above solution inside the tank container 23 () is transferred = to the above temperature Water is stored inside the dissolution tank 250, because the liquid concentration at this time is Hou Yi, the required product concentration is 46% high-point, supply additional G. 87βtons of warm water to the above-mentioned warm water preservation ridge solution tank 25G, start The mixing device 258, which is located in the warm water retention and dissolution tank 25 in advance, is used to fine-tune the final concentration. The solution collected in step S2 is the warm water portion of the above ㈣, which is added in the above method and reused. In this way, as described in the first paragraph, 60.8 tons of 46% solution is adjusted in the above-mentioned warm water retention and dissolution tank 25, and the entire work of step S4 is completed. In step S5, the solution prepared as described above is supplied to the above storage tank 9. When the solution is injected, the above-mentioned door is closed, and the above-mentioned door, Ba, Be is opened by touching ^, and the above liquid is injected. The human pumps pa, pb operate in a normal rotating manner, as shown by the arrow in FIG. 20 'All the solutions in the above-mentioned warm water retention and dissolution tank 25 () are transferred to the above-mentioned storage tank 9' and the above-mentioned storage tank 9 is stored The above-mentioned drug M solution is used for paper bleaching. Next, stop all drive systems, _ all the above, and remove all connections 2049-6929-PF; Ahddub 25 200533566. Connectors 240c, 243c, 244c, so separate all the tanks 230 and warm water The transport system between the dissolution tanks 250 is stored, and the solution leaked from the connector is accumulated in the clean water and leaked liquid collection trays, collected and reused in the next dissolution, and before the drive system is stopped, it is located in the reverse direction. The mixing device 233 of the tank container 230 then retracts the above-mentioned bracket 221 for protecting the shaft, and all the above-mentioned preparations are restored to the above-mentioned initial state, and all the above-mentioned steps S5 are completed. As described above, in the second medicine delivery method, the powder medicine is mixed and circulated between the tank container 230 on the supply side and the warm water retention and dissolution tank 250 on the use side in a short time. A large amount of ® drug solution can be prepared inside, and the cost is greatly reduced. During the dissolution or promotion of the dissolution of the powdered medicine, it is preferable to prevent the temperature of the warm water from decreasing, and it is better to supply water vapor to the tank 230, and therefore it is better to have a water vapor supply device on the user side in advance. [Industrial application] Although the powder medicine described in all the above embodiments of the present invention is sodium chlorate, the present invention is not limited to the transportation of the above medicines, but can be effectively applied to the transportation of powder medicines dissolved in solvents. Especially about, especially about the storage, transportation, dissolution and transportation of φ requires safe and harmless powdered dangerous drugs. [Brief description of the drawings] FIG. 1 is a schematic diagram of the flow of a first drug delivery method according to the present invention; FIG. 2 is a side view of a drug delivery trailer; and FIG. 3 is a tank container loaded on the trailer (A) is a side sectional view, (B) is a plan view, (C) is a cross-sectional view taken along line XX in (A); FIG. 4 is a perspective view of the outer surface of the above tank container; The picture is a flat 2049-6929-PF; Ahddub 26 200533566, which is filled with the above medicine into the above tank container and supported by a lifting device. The figure 6 is a side view of figure 5; the middle one is used for connection and disassembly. The front view of the connection mechanism of the medicine storage bag, (A) is the state before being fixed, and (B) is the state after being fixed; Figure f8 is a front view of the weight detection automatic shaking mechanism; Figure 9 is A cross-sectional view of the medicine holding bag when it is opened; 的 = side view of the tank container at the medicine receiving place (medicine dissolution chamber); the figure is a cross-sectional view of the structure of the combined device, and its body is fixed, (β) is Ascension can be set as the main view (::: = 广-侧: It is a side view of the above tank container at the medicine receiving place; Figure 15 is a view of the above tank container and a cross-sectional view; Figure 16 of the transfer pipeline system between the storage and dissolution tanks is a cross section of the solvent storage state. Figure 17 shows the shape of the medicine in the above tank; Figure 17 shows the sample of the drug in the above; Figure 9 shows the cross section of the dissolved state within 9 σ. Side view Figure 18 shows the drug solution in the sample and mixed state. Side sectional view; ㈢ ^ Cycles between solvent storage and dissolution tanks. Figure 19 shows the above-mentioned solvent storage and dissolution tanks. Figure 20 is a cross-sectional view of a kiss, ridge-like liquid that is ready for transmission. Figure 21 shows the section of the state of the drug solution. Figure 21 shows the medicine of the conventional technology. Figure 22 shows the outline of the flow of the know-how; and the outline of the technology slave m. 2049-6929-PF Ahddub 200533566 [Description of symbols of main components] 1 ~ medicine container; 3 ~ transport truck; 9 ~ storage tank; 10 ~ trailer; 12 ~ lifting device; 100 ~ trailer; 120 ~ lifting device; 131 ~ circumference Wall; 133 ~ mixing device; 135 ~ circulation tube 139 ~ liquid level detector; 170 ~ collection box; 200 ~ trailer; 220 ~ lifting device; 231 ~ circumferential wall; 233 ~ mixing device; 239 ~ liquid level detector; 280 ~ medicine receiving place. 1F ~ bag; 2 ~ dangerous drug storage warehouse (supply side); 4 dangerous drug storage warehouse (user side 11 ~ traction machine; '13 ~ tank container; 110 ~ traction machine; 130 ~ tank container; 132 ~ injection port; 134 ~ Catheter fixing port; 137 ~ discharge port; 160 ~ lifting device; 180 ~ medicine receiving place; 210 ~ tractor; 230 ~ tank container; 2 3 2 ~ injection port; 234 ~ catheter fixing port; 250 ~ warm water preservation Dissolution tank; 2049-6929 ~ PF; Ahddub

Claims (1)

200533566 .十、申請專利範圍: 1. 一種藥品傳送方法,傳送溶於溶劑的粉狀藥品,以供應上述 藥品溶劑給用戶,包括: 步驟S1,儲存含有一既定重量的藥品於袋子中在儲存庫房中; 步驟S2,打開含有上述藥品的袋子,放入上述藥品至一槽容器 並在運送到用戶的過程中,在上述槽容器中保持上述在藥品的粉末 狀態; 步驟S3,利用拖車運送含有上述藥品的槽容器到上述用戶的藥 品接收處, ® 步驟S4,在上述藥品接收處提供溶劑和蒸氣至上述槽容器,混 合並溶解上述藥品以得到一既定濃度的溶液;以及 步驟S5,供應在上述步驟S4溶解的藥品溶液到上述用戶的儲存 槽。 2. —種藥品傳送方法,有效達到傳送溶於溶劑的粉狀藥品,以 運送相同的藥品給用戶,包括: 步驟S1,健存含有一既定重量的藥品於一袋子中在儲存庫房中; 步驟S2,打開含有上述藥品的袋子,放入上述藥品至一槽容器 • 並在運送到用戶的過程中,在上述槽容器中保持上述在藥品的粉末 狀態; 步驟S3,利用拖車運送含有上述藥品的槽容器到上述用戶的藥 品接受處; 步驟S4A,在上述藥品接收處自位於用戶端的溶劑儲存溶解槽, 提供溶劑至上述槽容器内部,混合循環以溶解上述藥品而得到一既 定濃度的溶液;以及 步驟S5,供應在上述步驟S4A溶解的藥品溶液到上述用戶的儲存 槽0 2049-6929-PF;Ahddub 29 200533566 一 3·如申請專利範圍第⑷項所述之藥品輪送, 狀藥品為氯酸鈉,而溶劑為溫水。 其中上述粉 4·如申請專利範圍第!至3項中任―項所述之藥 〜 中上述溶劑由用戶提供。 、°口别送方法,其 5.如申請專利範圍第2至4項中任一項所述之藥品 中上述溶劑自上述溶劑保存溶解槽的高度方向位置排:廷方法’其 應至上述槽容器的底部而注入上述槽容器的内部 ^盾環,供200533566. Scope of patent application: 1. A method for drug delivery, delivering powdered drugs dissolved in a solvent to supply the above-mentioned drug solvent to the user, including: Step S1, storing a drug containing a predetermined weight in a bag in a storage warehouse Step S2: Open the bag containing the medicine, put the medicine into a tank container, and keep the powder state of the medicine in the tank container during transportation to the user; Step S3, use a trailer to transport the medicine containing the above The tank of the medicine to the medicine receiving place of the user, step S4, providing the solvent and vapor to the tank container of the medicine receiving place, mixing and dissolving the medicine to obtain a solution of a predetermined concentration; and step S5, supplying the above Step S4 dissolves the medicine solution into the storage tank of the user. 2. A medicine delivery method, which can effectively deliver powdered medicines dissolved in solvents to deliver the same medicines to users, including: Step S1, storing a medicine containing a predetermined weight in a bag in a storage warehouse; steps S2. Open the bag containing the medicines, put the medicines into a tank container, and keep the powder state of the medicines in the tank containers during transportation to the user. Step S3, use a trailer to transport the medicines containing the medicines. The tank container to the user's medicine receiving place; step S4A, at the medicine receiving place, a solvent storage dissolving tank located at the user side is provided, the solvent is provided to the inside of the tank container, and the mixture is circulated to dissolve the medicine to obtain a solution of a predetermined concentration; and Step S5, supply the medicine solution dissolved in the above step S4A to the storage tank of the above user 0 2049-6929-PF; Ahddub 29 200533566 1-3. The medicine is rotated as described in item ⑷ of the scope of patent application, and the medicine is chloric acid Sodium and the solvent is warm water. Among the above-mentioned powders 4 · If the scope of patent application is the first! Any one of the three items-the medicine mentioned in the one ~ The above solvents are provided by the user. , ° Do not send method, which 5. The medicine as described in any one of the scope of application for patents 2 to 4 above the solvent from the above-mentioned solvent storage dissolution tank in the height direction row: Ting method 'it should go to the above tank The bottom of the container is injected into the inside of the tank container. 部混合,自上述槽容器高度方向位置排出,而自内 槽的底部回到上述溶劑保存溶解槽内部。 ’、存4解 6.如申請專利範圍第5項所述之藥品輸送方法,其中當上、,、一亦 由上述溶劑保存溶解槽的底部回到上述溶劑保持溶解^劑 述溶劑以水平方向擴散。 ㈢。%,上 ^ 7·如申請專利範圍第1至6項中任一項所述之藥品輸送方法,其 中藥ππ在步驟S2中注入後,由清洗水清洗上述槽容器表面,而在二 解上述藥品至一既定濃度的溶液時重覆利用上述清洗水。 如The part is mixed and discharged from the height position of the tank container, and returns to the inside of the solvent storage dissolution tank from the bottom of the inner tank. '、 Storing 4 solutions 6. The method for drug delivery as described in item 5 of the scope of the patent application, wherein the upper, lower, and lower sides of the solvent storage and dissolving tank are returned to the above solvents to maintain dissolution. diffusion. Alas. % ^ 7. The medicine delivery method according to any one of claims 1 to 6 in the patent application scope, wherein after the medicine ππ is injected in step S2, the surface of the above-mentioned tank container is washed with washing water, and the above solution is used in the second solution. When the medicine reaches a solution of a predetermined concentration, the above-mentioned washing water is repeatedly used. Such as 2049-6929-PF;Ahddub 302049-6929-PF; Ahddub 30
TW094107674A 2004-03-25 2005-03-14 Method of transporting medicaments TW200533566A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004090182A JP3922377B2 (en) 2004-03-25 2004-03-25 How to transport chemicals
JP2004221750A JP3806722B2 (en) 2004-07-29 2004-07-29 How to transport chemicals

Publications (1)

Publication Number Publication Date
TW200533566A true TW200533566A (en) 2005-10-16

Family

ID=35262747

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094107674A TW200533566A (en) 2004-03-25 2005-03-14 Method of transporting medicaments

Country Status (3)

Country Link
KR (1) KR100728719B1 (en)
CN (1) CN100408377C (en)
TW (1) TW200533566A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012112815A1 (en) * 2012-12-20 2014-06-26 Bayer Technology Services Gmbh Process unit and use of several process units
CN110316555B (en) * 2018-03-31 2021-02-12 世博生态环保技术股份有限公司 Method for recycling wastewater by using robot arm and robot arm adopting method
TW202028106A (en) * 2018-12-17 2020-08-01 美商安林公司 Storage and transport system and method for solid sodium hypochlorite pentahydrate

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5183293A (en) * 1991-05-23 1993-02-02 Julian Vincent D Waste management system
CN1061001A (en) * 1991-11-09 1992-05-13 山西省农业机械化学校 Multi-function fluid pumping and storage equipment
IT1257556B (en) * 1992-11-27 1996-01-30 Lawer Srl DEVICE FOR THE PREPARATION OF MIXTURES, FOR EXAMPLE FOR THE PREPARATION OF DYEING SOLUTIONS IN TEXTILE PLANTS.
JP2821108B2 (en) * 1996-09-26 1998-11-05 株式会社日阪製作所 Drug dissolution supply device and drug-filled container used for the same
JPH11123321A (en) * 1997-10-22 1999-05-11 Arusu:Kk Device for dissolving a plurality of kinds of solutes
CN1100980C (en) * 1998-04-23 2003-02-05 李光福 Conducting medium and conduction-type electric heater
JP2001025650A (en) * 1999-07-12 2001-01-30 Japan Organo Co Ltd Powder injection and dissolution apparatus
NZ513159A (en) * 1999-12-03 2002-10-25 Baxter Int Method and apparatus for controlling the strategy of compounding pharmaceutical admixtures
JP4488462B2 (en) * 2000-12-26 2010-06-23 日本曹達株式会社 Alkali metal dispersion container
JP3847566B2 (en) * 2001-02-07 2006-11-22 昭和飛行機工業株式会社 Granular material carrier
JP2003181252A (en) * 2001-12-14 2003-07-02 Nisshin Kako Kk Method and apparatus for hydrating and dissolving powder
JP4100009B2 (en) * 2002-03-11 2008-06-11 ニプロ株式会社 Automatic powder melting equipment

Also Published As

Publication number Publication date
CN1683186A (en) 2005-10-19
KR20060044762A (en) 2006-05-16
CN100408377C (en) 2008-08-06
KR100728719B1 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
US6537450B2 (en) Centralized bicarbonate mixing system
US9272092B2 (en) Machine and method for the automatic preparation of intravenous medication
AU684323B2 (en) Method and equipment for sanitization of medical waste
JPH07184993A (en) Blood dialyser
TW200533566A (en) Method of transporting medicaments
JP2006271835A (en) Apparatus for dissolving medical agent
US5865343A (en) Chemical dispensing system
CN205773320U (en) A kind of chlorine dioxide generator
KR20100076379A (en) Agricultural medicines tank
CN214126891U (en) Raw materials degassing unit is used in laying duck feed processing
CN211381972U (en) Animal doctor is with atomizing device of dosing
JP3806722B2 (en) How to transport chemicals
CN207708853U (en) A kind of insecticide, disinfectant is prepared automatically and spraying system
CN207645834U (en) A kind of sewage chemical feeder
CN207324715U (en) Real-time continuous formula mixes medicine platform
CN208036970U (en) A kind of ampoule bottle batch holder with sterilizing function
CN206853603U (en) A kind of mixer provided with online bactericidal unit
CN206506849U (en) A kind of Chinese garden planting seed separates disinfection unit
CN205586607U (en) Convenient traditional chinese medicine of arranging sediment draws jar
CN211185392U (en) Water supply and epidemic prevention liquid medicine centralized supply device for black pig breeding facility
CN105167998B (en) The method that cream overall process is received in traditional Chinese medicine extraction concentration is realized in non-clean area
CN219647195U (en) Non-contact powder solvent mixing equipment
CN218249909U (en) Vacuum mixing tank
CN209378815U (en) A kind of chemicals dosing plant
CN206643073U (en) A kind of XiLin bottle plug sterilizing-drying device